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Copper is an essential cofactor for many metalloproteins, yet it can also be 
cytotoxic, therefore, intracellular copper trafficking is tightly regulated. Copper 
delivery inside cells is mediated by copper chaperones, which bind and deliver copper 
to their target proteins, preventing adventitious chemical reactions with the metal. 
Various pathways for copper transport exist; of particular interest to this thesis is the 
pathway between the copper chaperone Hah1 and Wilson disease protein (WDP).  
Limited dynamic information is available on how the copper chaperone Hah1 
and the metal binding domains (MBDs) of WDP interact for copper transfer. In this 
thesis, the interaction dynamics of Hah1 and a single MBD of WDP is investigated. 
Since these protein-protein interactions are relatively weak in nature, a nanovesicle 
trapping strategy is used to increase the effective concentration of single molecules 
(Chapter 2). Individual interaction events are then monitored by single-molecule 
Förster resonance energy transfer (smFRET). 
The interaction dynamics of Hah1 and the fourth MBD (MBD4) of WDP are 
initially studied in the absence of copper. The protein-protein interaction scheme and 
associated rate constants for the interaction process are extracted from the FRET 
efficiency (EFRET) and waiting-time distributions (Chapter 3). The EFRET distributions 
obtained from interactions in the absence and presence of copper are then used to gain 
insight on the underlying copper transfer process (Chapter 4).  
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Introduction 
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Transition metals, such as copper and iron, are essential as cofactors to a 
variety of proteins and enzymes.1 Under physiological conditions, copper can adopt 
two oxidation states (Cu(I) or Cu(II)), which makes it useful as a catalytic cofactor to 
many metalloproteins that carry out redox reactions. Despite its usefulness as a 
catalytic cofactor, copper can also be very toxic to cells. Although the molecular 
mechanisms that cause this toxicity are not entirely clear, it is well known that copper 
can catalyze Fenton radical chemistry producing reactive oxygen species (Scheme 
1.1): 
 
H2O2 OH + OH
Cu(I) Cu(II)  
Scheme 1.1. Fenton reaction. 
These reactive oxygen species, such as hydroxyl radicals, can cause oxidative damage 
to lipids, proteins and DNA, as well as many other biomolecules.2 Therefore, the 
concentration, availability, and trafficking of copper within cells must be tightly 
regulated. 
 Cells have evolved different mechanisms for safe trafficking of copper ions 
and regulation of copper concentrations.3,4 A multitude of copper-binding molecules 
such as glutathione, metallothionein and metallochaperones exist to bind and protect 
copper from otherwise biologically harmful reactions. Copper chaperones function as 
a shuttle system for copper. They bind copper with high affinity, thus protecting 
against adventitious reactions, as well as deliver copper to specific target proteins, 
thereby ensuring safe metal trafficking. These target proteins, in turn, transport copper 
to copper-dependent enzymes or mediate copper efflux from the cell. 
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1.1. Cellular copper trafficking  
Copper is imported into eukaryotic cells as Cu(I) by members of the Ctr family 
of copper transporters (Figure 1.1).5 Once inside the cytosol, soluble Cu(I)-binding 
proteins called copper chaperones deliver copper to target proteins via direct protein-
protein interactions.6 It is not clear how the chaperones obtain copper, but it may be 
through a direct interaction with the Ctr transporters.7  
The copper chaperone for superoxide dismutase (CCS)8 delivers copper to the 
antioxidant enzyme Cu,Zn superoxide dismutase (SOD1) (Figure 1.1).9 Metallation of 
SOD1 occurs primarily in the cytosol, but a small amount of SOD1 is also localized to 
the mitochondrial intermembrane space if CCS is also present there.10 SOD1 catalyzes 
the disproportionation of superoxide anion to oxygen and hydrogen peroxide.11 
 
 
Figure 1.1. Two Intracellular copper transport pathways in eukaryotic cells. The 
number of MBDs in the ATPases can vary from n = 1 in yeast to n = 5 in humans. 
The Atx1-like chaperones transfer Cu(I) to membrane-bound, copper 
transporting P1B-type ATPases. In yeast, Atx1 delivers Cu(I) to Ccc2 in the trans-
Golgi network.12 Ccc2 then translocates copper into secretory vesicles, where it is 
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loaded into the enzyme Fet3.13 The human homologue of Atx1, known as Hah1 or 
Atox1,14 delivers copper to the Menkes and Wilson disease ATPases (ATP7A and 
ATP7B, respectively) for ultimate incorporation into copper dependent enzymes such 
as ceruloplasmin or for copper efflux. Fet3 and ceruloplasmin are multicopper 
oxidases that play a role in iron metabolism by catalyzing the oxidation of Fe(II) to 
Fe(III) at the plasma membrane.15 Ccc2 and the Menkes/Wilson disease proteins all 
belong to the P-type ATPase superfamily of integral membrane proteins that couple 
the energy of ATP hydrolysis to cation translocation across membranes.16,17 The Cu(I) 
transporting P1B-type ATPases consist of eight transmembrane helices, a cytoplasmic 
ATP binding (ATPBD: composed of N and P domains) and actuator domains (A 
domain), and multiple N-terminal soluble metal binding domains (MBDs) (Figure 
1.2).18 The number of MBDs vary, ranging from two in Ccc2 to six in the 
Menkes/Wilson disease proteins.19,20 
 
 
Figure 1.2. Overall structural model for ATP7A and ATP7B P1B-type ATPases. 
Transmembrane segments are numbered, remaining domains are indicated.  
 
1.2. The Cu(I) ATPase ATP7B and the Hah1 copper chaperone  
Mutations on ATP7A or ATP7B can lead to Menkes and Wilson diseases, 
respectively.21-23 Both are diseases of copper metabolism associated with copper 
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absorption and efflux. The main focus of this thesis is on the human copper transport 
pathway from the intracellular copper chaperone Hah1 to the copper transporting 
ATPase, ATP7B, the Wilson disease protein (WDP) (Figure 1.3). 
 
 
Figure 1.3. Copper transport pathway from the Hah1 copper chaperone to Wilson 
disease protein. 
 
Hah1 is a soluble, single domain, cytoplasmic protein, belonging to the Atx1-
like copper chaperone family.6, 24-29 WDP is a multidomain protein that is anchored on 
the trans-Golgi membrane and has a soluble N-terminal region consisting of six 
homologous metal-binding domains (MBDs).21, 22, 30  WDP mediates the translocation 
of copper to copper dependent enzymes as well as copper efflux from the cell. Two 
characteristic features for both the Hah1 chaperone and the WDP MBDs 6, 24-29, 31-34 
are a conserved, surface-exposed, MXCXXC motif, where the two cysteines bind 
copper, and a βαββαβ ferredoxin-like protein fold (Figure 1.4). The similarity in 
protein fold between the chaperone and WDP MBDs renders their specific interactions 
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through complementary surface residues.32, 34, 35 Copper is transferred as Cu(I) from 
Hah1 to the MBDs of WDP by means of direct and specific protein-protein 
interactions.12, 24, 25, 32, 34, 35  
Past studies have shown that the six MBDs of WDP have different functional 
roles:32, 36-42 MBDs 1 to 4 are important for interaction with Hah1 to acquire copper 
and MBDs 5 and 6 are critical for copper translocation through the membrane. 
Interestingly, NMR studies performed with a full six domain construct of the N-
terminal MBDs show that Hah1 can transfer copper to all MBDs, yet only domains 1, 
2 and 4 can form detectable adducts with Hah1, and only in the presence of Cu(I).43 
 
 
Figure 1.4. Solved WDP MBD structures and Hah1. 
 
1.2.1. Hah1 and MBD structural data 
Much structural information has been obtained from NMR and x-ray 
crystallography studies on the Atx1-like chaperones and the MBDs of their target 
proteins. The Hah1 structure has been solved in the presence of copper, mercury and 
cadmium, as well as in its apo form.44  The structures solved by crystallography are 
homodimeric, with the metal sandwiched between two protein units. The metal 
coordination varies between 3 and 4 coordinate depending on the metal.44 The 
homodimeric structures have served as a model for interaction with the MBDs for 
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many years. A recent heterodimeric structure between the first MBD of Menkes 
disease protein (MNK1) and Hah1 shows this same mode of interaction in which both 
proteins face each other on their metal binding motif (Figure 1.5).45 
The structures for the individual MBDs of MNK have also been fully solved 
by NMR in the presence of Cu(I) or Ag(I) and in the absence of metal. All the 
domains bind copper in a 2 coordinate fashion. MBDs 1 and 2 of WDP have not been 
fully solved as of yet, but domains 3 through 6 have. In the WDP case only the apo 
structures have been solved (Table 1.1). A comprehensive review is available of all 
solved structures for the atx1-like chaperones and their respective ATPase target 
MBDs up to the year 2009.46  
 
 
Figure 1.5. Heterodimer structure of Hah1 and the first metal binding domain of 
Menkes disease protein (MNK1). The red circle indicates the two metal binding motifs 
facing each other with copper sandwiched in between. 
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Table 1.1. Known WDP/MNK MBD and Hah1 structures. 
 
Structure Type PDB ID Reference 
Hg(II)-Hah1 X-ray 1FE4 34 
Cd(II)- Hah1 X-ray 1FE0 34 
Cu(I)- Hah1 X-ray 1FEE 34 
Cu(I)- Hah1 NMR 1TL4 47 
Apo- Hah1 NMR 1TL5 47 
Apo-MNK4 NMR 1AW0 48 
Ag(I)-MNK4 NMR 2AW0 48 
Apo-MNK2 NMR 1Q8L 49 
Apo-MNK2 NMR 1S6O 50 
Cu(I)-MNK2 NMR 1S6U 50 
Apo-MNK1 NMR 1KVI 51 
Cu(I)-MNK1 NMR 1KVJ 51 
Apo-MNK3 NMR 2G9O 52 
Cu(I)-MNK3 NMR 2GA7 52 
A69P apo-MNK6 NMR 1YJR 53 
A69P Cu(I)-MNK6 NMR 1YJT 53 
Apo-MNK6 NMR 1YJU 53 
Cu(I)-MNK6 NMR 1YJV 53 
Apo-WD56 NMR 2EW9 36 
Apo-WD34 NMR 2ROP 54 
WD-N-Domain NMR 2ARF 55 
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1.2.2. Previous Hah1-MBD interaction studies 
Rosenzweig and others showed that all WDP MBDs, as well as Hah1, have 
similar copper binding affinities.42, 56 This similarity indicates that the Hah1 to WDP 
copper transfer is under kinetic control mediated by Hah1-WDP interactions, and that 
the functional differences among WDP MBDs are not defined by their Cu(I) binding 
affinities but may be related to how each MBD interacts with Hah1 and other MBDs. 
Very limited quantitative information is available, however, on how Hah1 and WDP 
interact, other than the surface plasmon resonance (SPR) studies on the association 
and dissociation kinetics of related systems by Solioz,57 Mercer58 and coworkers. 
These SPR studies employed nonspecific surface immobilization of proteins, which 
can influence protein interaction kinetics. Different NMR studies have been performed 
with different MBD constructs to probe their inter- and intra-molecular interactions. 
Huffman and coworkers36 59 showed copper transfer can occur between the MBDs of 
WDP via MBD-MBD interactions. In particular, the double-domain construct MBD56 
construct could not acquire copper from Hah1 but instead from the single-domain 
construct MBD4, which indicates the interdomain interactions and copper transfer are 
integral to WDP-mediated copper transport. As mentioned above, experiments 
performed on the full N-terminal MBD tail of WDP actually show that Hah1 is 
capable of metallating all of the MBDs.43 There is still some disagreement on how 
copper is handled between Hah1 and the MBDs of WDP, which may have a 
foundation on how the different MBDs and Hah1 interact. In addition, limited kinetic 
information is available on the interaction processes.  
Interdomain interactions will not be addressed in this dissertation, yet the 
fundamental process of interaction between a single MBD and Hah1 is scrutinized. 
These may serve as a foundation to a better understanding of how MBDs and Hah1 
interact for metal transfer.  
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1.3. The single-molecule approach to study weak, dynamic protein interactions  
In general, weak, dynamic protein interactions, such as those between Hah1 
and the MBDs, are difficult to quantify in ensemble experiments for various reasons: 
(1) They are stochastic, making synchronization of molecular actions necessary. (2) 
The steady state concentrations of interaction intermediates are often low. (3) The 
presence of multiple interaction intermediates convolutes ensemble-averaged 
measurements. In contrast, single-molecule experiments offer several advantages for 
studying these interactions: (1) No synchronization is needed. (2) Molecular actions 
are followed in real time, and so are the formation, interconversion, and dissolution of 
interaction intermediates. (3) Only one molecular state, be it an intermediate, is 
observed at any given time. For these reasons, the single molecule approach provides a 
unique means to characterize weak dynamic protein interactions. This dissertation 
focuses on the single molecule characterization of the interactions between the copper 
chaperone Hah1 and the fourth metal binding domain of Wilson disease protein 
(MBD4).  
 
1.3.1. Single-molecule Förster resonance energy transfer (smFRET)  
Single molecule Förster (or Fluorescence) Resonance Energy Transfer 
(smFRET) is the nonradiative transfer of electronic excitation energy from a single 
donor to a single acceptor dye molecule via a weak dipole-dipole coupling 
mechanism. The transfer efficiency was predicted by Förster to decrease with the 
distance between the two dyes, as [1 + (R/R0)6]-1 (Figure 1.6), where R is the distance 
between the two dyes and R0 is the Förster radius.60 The Förster radius is the distance 
corresponding to 50% energy transfer and depends on the photophysical properties of 
the dyes and their relative orientations. Due to its long-range distance dependent 
behavior, FRET can be used as a spectroscopic ruler to determine relative dye to dye 
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distances typically in the range of 2 to 8 nm.61 Past studies have shown that smFRET 
is well suited for studying conformations and dynamics of biological 
macromolecules.62-66 SmFRET has been successfully used in a variety of biological 
applications from protein and DNA conformational dynamics62-64, 66-69 to enzyme 
reactions.70    
SmFRET measurements can be used not only to probe average distances as in 
an ensemble experiment but also to observe distributions and the time evolution of 
conformational properties directly. The FRET efficiency (EFRET) can be expressed in 
terms of kD and kT, the donor-only fluorescence and the energy transfer rate constants, 
respectively. Because the transfer process results in an excited state for the acceptor, 
the efficiency of energy transfer can be rewritten in terms of the donor (ID) and 
acceptor (IA) fluorescence intensities as:  
 
)/(1
1
)/(1
1
)/(1
1
ADADTDTD
T
FRET IIIIkkkk
kE    
 
where γ (= ηAφA/ηDφD) is a correction factor that accounts for the detection 
efficiencies (η) and fluorescence quantum yields (φ) for the individual dyes.60, 61, 70 
Hence, direct detection of the individual fluorescence intensities of individual dyes 
affords a direct determination of the efficiency of energy transfer. The correction 
factor γ can be measured directly by determining the ratio ΔIA/ ΔID, where ΔIA and 
ΔID are the acceptor and donor intensity changes on acceptor photobleaching. This 
value was experimentally determined by Ha and coworkers to be ~1 from 45 
individual molecules.70   
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Figure 1.6. FRET efficiency as a function of distance (R).  
 
1.3.2. Protein interaction dynamics studied by smFRET  
SmFRET has become a common tool for characterizing protein dynamics at 
the single molecule level. Previous studies of protein-protein interactions include the 
chaperonin system GroEL-GroES interactions,71 Wiskott-Aldrich Syndrome protein 
and Cdc42 protein interactions for cell signaling,72 chymotrypsin inhibitor 2 and 
subtilisin BPN’ interactions,73 and protein-enzyme interactions in energy conversion 
systems.74 Individual protein-protein events were followed and the associated protein 
interaction dynamics were deconvoluted. Further examples can be found in protein-
DNA interactions from metalloregulators to enzymes involved in DNA replication.62, 
63, 66, 75, 76  
There are challenges to overcome before single-molecule methods can be 
applied to probe any weak protein-protein interactions. The primary obstacle is the 
concentration limit. The fore mentioned examples involve relatively strong 
interactions. Single-molecule experiments are normally performed at low 
concentrations (10–9 to 10–12 M) of fluorescent species to separate molecules spatially 
for optical detection. This low concentration severely limits single-molecule studies to 
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strongly interacting proteins.77 Weak protein interactions with dissociation constants 
in the μM range are much more common in biology and need to be studied at higher 
concentrations. Nonspecific surface interactions present another challenge.65 These 
must be minimized when molecules are immobilized to follow them over time. 
Therefore, different ways to study weak, dynamic protein interactions at the single 
molecule level are needed.  
In this thesis, I will describe a nanovesicle trapping approach to overcome the 
above two challenges and enable smFRET study of weak, dynamic protein-protein 
interactions. 
 
1.4. Thesis outline 
 In this dissertation the weak, dynamic protein-protein interactions between the 
Hah1 copper chaperone and the fourth metal binding domain of Wilson disease 
protein are investigated. Using a combination of nanovesicle trapping and smFRET, 
the different behaviors of association, dissociation and complex interconversions are 
characterized under different conditions. 
 In chapter 2, the nanovesicle trapping strategy is described, detailing all the 
advantages and disadvantages of this approach as well as possible improvements. The 
theoretical approach to quantifying bimolecular binding events within the nanovesicle 
is described.  
The following chapters focus on the interaction dynamics between Hah1 and 
WDP MBD4. In chapter 3 the nanovesicle approach is used to study interactions 
between both proteins in the absence of any metal. The dynamics of association and 
dissociation, as well as complex interconversions are exposed from the single 
molecule data. In chapter 4 Hah1MBD4 interactions are studied in the presence of 
varying amounts of copper. The stabilization of different FRET populations and their 
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possible implications are discussed. These experiments and their results shed light into 
the fundamental interaction processes that take place between the copper chaperone 
and the metal binding domains of WDP.  
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CHAPTER 2 
Nanovesicle trapping for studying weak protein interactions by single-molecule 
FRET* 
 
 
 
 
 
 
 
 
 
 
* Benitez, J. J.; Keller, A. M.; Chen, P., Nanovesicle Trapping for Studying Weak 
Protein Interactions by Single-Molecule FRET. Meth. Enzymol. 2010, 472, 41-60. 
Reproduced with permission from Methods in Enzymology, Elsevier press. 
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2.1. Abstract 
Proteinprotein interactions are fundamental biological processes. While 
strong protein interactions are amenable to many characterization techniques including 
crystallography, weak protein interactions are challenging to study due to their 
dynamic nature. Single-molecule FRET can monitor dynamic protein interactions in 
real time, but are generally limited to strong interacting pairs because of the low 
concentrations needed for single-molecule detection. Here we describe a nanovesicle 
trapping approach to enable single-molecule FRET study of weak protein interactions 
at high effective concentrations. We describe the experimental procedures, summarize 
the application in studying the weak interactions between intracellular copper 
transporters, and detail the single-molecule kinetic analysis of bimolecular interactions 
involving three states. Both the experimental approach and the theoretical analysis are 
generally applicable for studying many other biological processes at the single-
molecule level. 
 
2.2. Introduction 
Proteinprotein interactions are essential for cellular functions including 
protein folding, cell signaling, and metal trafficking 1-3. The strength of 
proteinprotein interactions can vary widely depending on the proteins involved. 
Strong protein interactions can have equilibrium dissociation constants (KD) of a few 
picomolar (1012 M), for example antigenantibody interactions, for which tight 
binding is crucial 4. Weak protein interactions can have KD’s of a few micromolar to 
millimolar (106  103 M), for example interactions between metallochaperones and 
their target proteins, for which dynamic binding and unbinding are necessary to have 
many interaction turnovers 3, 5-10.   
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For understanding their fundamental properties, strong protein interactions are 
amenable to characterization by ensemble measurements, as stable interaction 
complexes can form even at dilute solution conditions. Stable protein complexes can 
further be crystallized for structural determination down to atomic resolution. In 
contrast, weak protein interactions are challenging to characterize in ensemble 
measurements for several reasons: (1) They are dynamic and stochastic, making 
synchronization of molecular actions often necessary. (2) The steady-state 
concentrations of interaction intermediates are often low, making detection difficult. 
(3) The presence of multiple interaction intermediates can complicate ensemble-
averaged measurements. To study these weak protein interactions, single-molecule 
measurements offer several advantages: (1) No synchronization of molecular reactions 
is necessary. (2) The molecular reactions, including the formation, interconversion, 
and dissolution of interaction intermediates, are followed in real time. (3) Only one 
molecular state, be it an intermediate, is observed at any time point, enabling the 
resolution of complex reaction kinetics.   
Single-molecule fluorescence resonance energy transfer (smFRET), with its 
inherent distance dependence in the nanometer scale, is particularly suited for probing 
dynamic proteinprotein interactions, which is accompanied by changes in 
proteinprotein distances. There are challenges to overcome, however, before 
smFRET can be applied to study weak protein interactions. The primary challenge is 
the concentration limit. Single-molecule fluorescence measurements are generally 
done at low concentrations (<109 M) to spatially separate fluorophores so that there is 
less than one fluorophore (or one pair of fluorophores) on average in the detection 
volume (about 1016  1015 L) monitored in confocal microscopy or total internal 
reflection microscopy. This low concentration range limits single-molecule protein 
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interaction studies to strong interacting pairs, whereas weak protein interactions need 
to be studied at much higher concentrations (> 106 M) to favor complex formation. 
To overcome this concentration limit, one needs to decrease the effective 
detection volume to ~10191021 L, so that at concentrations up to 106  104 M there 
is no more than one fluorophore on average found in it 11. This can be done by 
reducing the laser excitation volume or by confining molecules in space.  
For reducing the excitation volume, Webb, Craighead and coworkers have 
fabricated zero-mode waveguides made of metal-clad wells on top of a silica substrate 
12. The diameter of these wells is much smaller than the wavelength of the excitation 
light, and therefore, light shining at the silica substrate cannot propagate through the 
wells. This blockage of light propagation reduces the light excitation to an evanescent 
electromagnetic field close to the silica substrate surface, leading to reduction of the 
laser excitation volume to ~1021 L. Using this approach, Webb, Craighead and 
coworkers have studied the reactions of individual DNA polymerase molecules that 
have substrate binding affinity in the micromolar range. As these zero-mode 
waveguides are open reaction containers, a big advantage is easy exchange of 
solutions for changing reaction conditions. A disadvantage is the proximity of a metal 
surface to the fluorophore; the metal surface can influence the fluorophore’s 
fluorescence properties, such as its intensity and fluorescence lifetime. To follow 
individual molecules over time, the molecules also have to be immobilized on the 
silica surface at the bottom of the wells, which can introduce nonspecific surface 
interactions.  
For confining molecules spatially, trapping with nanometer-sized lipid vesicles 
is an effective approach (Figure 2.1), which was initially used in single-molecule 
studies of enzyme reactions 13, protein folding 14-17, and nucleic acid conformation 
dynamics 18, 19. Because of the confined volume, the effective concentration of a single 
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molecule inside a nanovesicle can be as high as tens of micromolar, while the overall 
concentration of the nanovesicles can be kept low to maintain the single-molecule 
detection condition. Using this nanovesicle trapping approach combined with 
smFRET measurements, Ha and coworkers have studied dynamic proteinnucleic acid 
interactions 20, and we have studied weak proteinprotein interactions at high effective 
concentrations 21, 22. In this article we describe in detail how nanovesicle trapping, 
combined with smFRET measurements, can be used to characterize weak, dynamic 
protein interactions at the single-molecule level. We also detail the single-molecule 
kinetic analysis of bimolecular interactions that show three FRET states. 
 
2.3. Nanovesicle trapping approach 
Nanovesicle trapping is an effective approach in reducing the effective 
detection volume to enable high concentration studies at the single-molecule level. 
This approach also offers several other advantages: (1) The lipid membrane enclosure 
mimics biological environments inside cells or organelles. (2) The membrane prevents 
nonspecific interactions between the protein and the glass surface because molecule 
immobilization is done via tethering the nanovesicle (Figure 2.1). Nevertheless, 
nonspecific interactions with the lipid membrane may occur; control experiments must 
be performed to check this possibility (see below). (3) The diameter of vesicles can be 
varied from a few hundred nanometers down to ~50 nm, covering effective 
concentrations up to ~24 M for a single molecule inside (Figure 2.2). (4) For 
proteinprotein interaction studies, interactions between molecules of the same type, if 
occurring, can be selectively discarded in the data analysis stage by examining only 
the nanovesicles that contain molecules of different types. 
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Figure 2.1. Schematics of nanovesicle trapping of two proteins labeled with a FRET 
donor-acceptor pair for smFRET studies.  
 
In this section, we describe the experimental details of preparing nanovesicles 
to trap two different proteins for protein interaction studies. The procedures largely 
follow those of Haran and Ha 14, 18. 
 
Figure 2.2. Dependence of the effective concentration of a single molecule on the 
diameter of the nanovesicle. The solid symbols indicate a few commercial available 
membrane pore sizes for preparing nanovesicles. 
 
2.3.1. Lipid selection 
The lipids for forming the membrane bilayer of the nanovesicles contain two 
components: one major lipid (~99%) that dominates the behavior of the membrane 
bilayer and the other minor lipid (~1%) that contains a biotin group for surface 
immobilization. The chemical nature and the gel-to-liquid phase transition temperature 
(Tm) of the major lipid are important here. The lipid must not significantly interact 
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with the proteins and perturb the protein interactions. A lipid with a net zero charge is 
preferred, as it is less likely to interact with soluble, largely hydrophilic proteins 14. 
Usually the Tm of the major lipid should be much lower than the temperature for the 
single-molecule experiments, so the lipid bilayer stays in the fluidic liquid phase. A 
common major lipid used in single-molecule applications is Egg PC, extracted from 
egg yolk and ~99% of which is L-α-phosphatidylcholine. Its Tm is about 2°C 23, so its 
bilayer is in the liquid phase at room temperature. Many other lipids with different Tm 
and charge properties are available and can be used for preparing vesicles 23. For the 
biotinylated minor lipid, Biotinyl-cap PE (1,2-Dipalmitoyl-sn-Glycero-3-
Phosphoethanolamine-N-(Cap Biotinyl)) is commonly used. 
 
2.3.2. Lipid nanovesicle preparation and protein trapping 
The procedure consists of two major steps: (1) Preparation of dry lipid film and 
hydration of the lipid film with buffer containing fluorescently labeled proteins to 
form vesicles and trap proteins inside. (2) Extrusion of the formed vesicles through a 
polycarbonate membrane with well-defined pore diameters to make unilamellar 
vesicles of defined size. Using 100-nm pore-size membranes for extrusion, the 
multilamellar vesicles were estimated to be less than 2% 24. 
 
2.3.2.1. Lipid film preparation and hydration 
1. Prepare lipid stock solutions in chloroform at 100 mg mL1 and store at 20 °C 
in a desiccator. The biotinylated lipid stock solution is prepared at 1 mg mL1. 
2. Transfer aliquots of lipid solutions into a clean glass test tube, forming a 
solution of ~99% major lipid and ~1% biotinylated minor lipid. Use enough 
amounts for a final total lipid concentration of 5 mg mL1 upon hydration. Dry 
under a nitrogen flow until a thin lipid film is formed on the wall of the test 
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tube. The lipid film can be further put under vacuum for 1 – 2 h to remove 
residual chloroform. 
3. Hydrate the lipid film with the solution containing a mixture of the two labeled 
proteins under study. The concentration of each of the fluorescently labeled 
proteins should be close to the targeted effective concentration when the 
protein is trapped inside the nanovesicle. For example, for trapping a pair of 
protein molecules in 100 nm diameter nanovesicles, the concentration of each 
protein should be ~3 µM, whereas for trapping in 200 nm diameter 
nanovesicles, use ~400 nM concentration. The efficiency of co-trapping a pair 
of molecules can be increased if the hydration and trapping are done under 
conditions where the protein pair has maximum binding affinity to each other.  
4. Briefly vortex the hydrated solution to detach the lipid film from the wall of 
the test tube. Incubate the solution for 10 min to 1 h at a temperature of at least 
10C above the Tm of the major lipid. The hydrated lipids will spontaneously 
form large multilamellar vesicles. Further freeze-thaw cycles (510 times) of 
the vesicle solution using liquid nitrogen and warm water can induce cracks in 
the membrane, which can improve entrapment of small molecules. Here care 
must be taken that the freeze-thaw cycles do not denature the proteins; circular 
dichroism spectroscopy can be used to check the folding state of the protein.  
 
2.3.2.2. Preparation of unilamellar nanovesicles via extrusion 
Unilamellar nanovesicles are formed by extrusion of the above vesicle solution 
through a polycarbonate membrane with nanometer-sized pores 24-26. Extrusion should 
be performed at a temperature of at least 10°C above the Tm of the major lipid. The 
Avanti mini extruder (Avanti Polar Lipids, Inc.) is handy for this purpose. 
Polycarbonate membranes of different pore diameters are available, ranging from 50 
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nm to a micron. The nanovesicle diameter obtained after extrusion follows a Gaussian 
distribution, the width of which is dependent on the number of passes through the 
extruder; the more passes, the narrower the distribution 24, 26. The diameter distribution 
can be checked using dynamic light scattering measurements. We normally perform 
tens of passes, significantly more than what is suggested by Avanti. The number of 
molecules trapped within the nanovesicles follows a Poisson distribution, with the 
average occupation number depending on the protein/lipid ratio in the hydration 
step14. The exact occupancy of each nanovesicle can be determined by single-
molecule fluorescence imaging (see Section 3.2).  
 
2.4. SmFRET measurements of weak proteinprotein interactions 
The smFRET experiments consist of: (1) immobilization of nanovesicles in a 
flow cell, and (2) real-time imaging using total internal reflection fluorescence 
microscopy.  The microscope is equipped with two-color detection for imaging the 
fluorescence of the FRET donor and acceptor simultaneously.  
 
2.4.1. Surface immobilization of nanovesicles 
To follow the proteinprotein interactions inside each nanovesicle over time, 
the nanovesicles need to be immobilized on a surface. A biotin-avidin linkage is most 
frequently used. Biotinylated lipids in the nanovesicle membrane are used to bind 
avidins (e.g., streptavidin or neutravidin), which in turn are bound to a biotin-modified 
surface. We have used three different schemes to modify the surface with biotins, all 
of which yield similar results: (1) coating the surface with a lipid bilayer containing 
biotinylated lipids, (2) coating with biotinylated bovine serum albumin (BSA), and (3) 
coating with partially biotinylated polyethylene glycol (PEG).    
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2.4.1.1. Lipid bilayer coating  
This surface modification scheme takes advantage of the spontaneous fusion of 
lipid vesicles onto clean quartz surfaces to form a lipid bilayer 27, 28, over which the 
nanovesicles can be attached. The lipids used for this bilayer can be the same as those 
used for the nanovesicles, e.g., 99% Egg PC and 1% Biotinyl-cap PE.  
1. The procedure for lipid preparation is the same as described earlier. The 
lipid film is prepared first and then hydrated with buffer in the absence of 
proteins.  
2. The hydrated solution is sonicated for 30 min to 1 h until clarity. The 
sonication here breaks large multilamellar vesicles to form small 
unilamellar vesicles, which can spontaneously fuse to clean quartz 
surfaces. The distribution of vesicle sizes is not important here.  
3. Incubate the quartz substrate with the solution containing small unilamellar 
vesicles at a total lipid concentration of 1 – 5 mg mL1 for 1 h. Wash out 
excess lipids from the quartz surface with buffer.   
4. Vesicle preparation, surface coating and washing should all be performed 
at a temperature of at least 10°C above the Tm of the major lipid.     
One problem using Egg PC for the supported bilayer is that at room 
temperature the bilayer exists in the liquid phase, so the attached nanovesicles are 
mobile. The nanovesicle mobility can be reduced by increasing the percentage of 
biotinylated lipid so that each nanovesicle is anchored to the supported bilayer by 
multiple biotin-avidin linkages 18. Nevertheless, many nanovesicles still remain mobile 
as we observed in our experiments. To alleviate this mobility problem, we have used 
another lipid, DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine), which has a Tm 
of ~41°C. Because of its high Tm, DPPC exists in the gel phase at room temperature, 
resulting in a mostly immobile lipid support.  
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2.4.1.2. BSA coating  
BSA can bind to quartz surfaces strongly via nonspecific interactions 29, and 
therefore, biotinylated BSA can be used to coat the quartz surface to immobilize 
nanovesicles: 
1. Prepare 1 mg mL1 biotinylated BSA solution and incubate on the quartz 
substrate for 30 min to 1 h.   
2. Wash out excess biotinylated BSA with buffer.  
 The BSA coating is easy to perform and can prevent rupture and fusion of 
nanovesicles to the quartz surface. (In case some bare patches on the glass surface 
exist due to incomplete coating with BSA, vesicle fusion to the glass surface can form 
patches of lipid bilayer to fill them up.)  
 
2.4.1.3. PEG coating  
Covalent functionalization of a quartz surface with partially biotinylated PEG 
is another scheme for immobilizing nanovesicles. The quartz surface is first covalently 
functionalized with amine groups, which are then covalently linked to PEG via 
succinimidyl ester chemistry.   
  
For amine modification: 
1. Prepare a fresh solution of 1.5-2% amino silane reagent (Vectabond, 
Vector Laboratories) in acetone. (Other types of amino silane reagents 
work too, for example, 3-aminopropyltriethoxysilane.) 
2. Drop 200 µL of the amino silane solution onto the quartz slide.  
3. Incubate for 5 minutes and then wash extensively with ultra-filtered, 
deionized water for 1 min. Dry slides with nitrogen and store under a dry 
environment.  
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 For PEG modification: 
1. Prepare a solution of 98~99% m-PEG-SPA-5000 and 1~2% biotin-PEG-
NHS-3400 (Nektar Therapeutics, JenKem Technology Inc., or SunBio 
USA) in 100 mM NaHCO3, pH 8.2.  
2. Drop 200 µL of the PEG solution onto an amine-functionalized slide and 
sandwich it with another slide. Place parafilm spacers in between to 
prevent squeezing out the solution. Incubate for 4 h in the dark.  
3. Wash slides thoroughly with nanopure water and dry with nitrogen for 
usage. 
 
2.4.2. Control experiments 
2.4.2.1. Lipidprotein interactions  
To check if the fluorescently labeled proteins have nonspecific interactions 
with the lipid membrane, one can coat the quartz surface with a lipid bilayer and flow 
in solutions containing high concentrations (e.g., 100 nM) of labeled proteins. After 
washing the flow cell with fresh buffer and imaging the single-molecule fluorescence, 
the number of molecules that are immobilized on the lipid bilayer by nonspecific 
interactions can be counted. Comparing the number of nonspecifically bound 
molecules to the number of molecules detected using specific biotin-avidin 
immobilization of nanovesicles provides an estimate of the extent of nonspecific 
interactions between the protein and the lipid membrane.18, 21, 22 
 
2.4.2.2. Occupancy of nanovesicles  
The nanovesicle trapping procedure will result in a distribution of occupancy 
of individual nanovesicles. The nanovesicle occupation is important to verify when 
using smFRET to study weakly interacting pairs. Under normal smFRET 
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measurements, only the FRET donor is continuously excited and emitting 
fluorescence. The FRET acceptor is emitting ideally only when it is close to the donor 
labeled protein (e.g., upon proteinprotein interaction) and is excited via energy 
transfer. The possible presence of multiple acceptor-labeled proteins within a 
nanovesicle can adversely affect quantitative determination of proteinprotein 
interaction kinetics. Control experiments are necessary to determine the distribution of 
occupancy of nanovesicles under the trapping conditions.      
To do so, one can use two different lasers to excite the FRET donor and 
acceptor separately. For example, for the Cy3Cy5 FRET pair, the Cy3 fluorescence 
can be directly imaged by excitation with a 532-nm laser and Cy5 fluorescence with a 
637-nm laser. With the nanovesicles already loaded with fluorescent proteins and 
immobilized on the surface, the control experiments follow: 
1. Directly excite the donor dye and record a movie of fluorescence intensity.  
2. Switch to the second laser to excite the acceptor dye in the same area and 
record a fluorescence movie. 
3. Analyze both movies to obtain fluorescence trajectories and positions of 
individual molecules. Use the number of photobleaching steps in the 
fluorescence intensity trajectory to determine the number of donor (or 
acceptor) molecules in the nanovesicle. 
4. Check the position colocalization if the donor and acceptor dyes belong to 
the same nanovesicle.  In our experience, incidental vesicle colocalization 
due to limited spatial resolution is minimal when the surface density of 
protein containing vesicles is smaller than 0.2 m2. 
For weakly interacting protein pairs, such as Hah1 and MBD4 (see Section 
3.3), the co-trapping efficiency is low. Among 340 nanovesicles containing either 
Hah1-Cy5 or MBD4-Cy3, only 21 of them contain a Hah1-Cy5 and a MBD4-Cy3.  
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The number of acceptor molecules can also be checked during normal 
smFRET measurements. One can first use the donor-exciting laser for smFRET while 
recording a fluorescence movie. In the later part of the movie, the acceptor-exciting 
laser is turned on to excite the acceptor dye until the acceptor photobleaches. The 
photobleaching events in the acceptor intensity will indicate the number of acceptor 
molecules in the nanovesicle. In this way one is sure to only examine single pairs of 
protein molecules. 
 
2.4.2.3. FRET differentiation of acceptor blinked/bleached states from the 
dissociated state of protein interactions  
Organic fluorescent dyes show blinking behavior, i.e., the fluorescence 
intensity sometimes switches off temporarily. Although fluorescence blinking can be 
suppressed significantly by using an oxygen scavenging system and triplet quenchers 
(e.g., Trolox) 30, occasional blinking of the FRET acceptor is problematic, as it would 
result in an apparently low FRET efficiency (EFRET = IA/(IA+ID), where IA and ID are 
the acceptor and donor fluorescence intensities), which could be mistaken as that of 
the dissociated state of proteinprotein interactions. Fortunately, using nanovesicle 
trapping and Cy3Cy5 as the FRET pair, the Cy5-blinked state has clearly lower 
EFRET than that of the dissociated state from control experiments 21, 22. 
As far as the apparent EFRET is concerned, the acceptor blinked state is 
effectively the same as that in the absence of the acceptor and that of the acceptor 
photobleached state. Therefore, the apparent EFRET from nanovesicles that merely 
contain a donor molecule serves as a control for signal from the acceptor blinked state 
(Figure 2.3A). The determined apparent EFRET with one Cy3 only is 0.04 ± 0.05, 
which is the same as Cy5-blinked/bleached state of a Cy3Cy5 pair (Figure 2.3C).  
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The dissociated state can be mimicked by a nanovesicle containing a free 
donor and a free acceptor (Figure 2.3B), as the free dyes do not interact with each 
other. Here the existence of both a donor and an acceptor must be confirmed by 
separate laser excitations (Figure 2.3B). Under 532-nm excitation, the apparent EFRET 
is 0.15 ± 0.14 (Figure 2.3C); the larger value here compared with that of Cy5-blinked 
state is likely due to the residual direct excitation of Cy5 fluorescence by the 532-nm 
laser and some energy transfer of Cy3 to Cy5 due to their confined coexistence inside 
the nanovesicle.  
 
2.4.3. Application to weak interactions between intracellular copper transporters 
We applied the nanovesicle trapping approach to enable smFRET studies of 
the weak, dynamic interactions between the human intracellular copper chaperone 
Hah1 and the fourth metal-binding domain (MBD4) of the copper transporting 
ATPase Wilson disease protein (WDP) 21, 22. The interactions between Hah1 and WDP 
mediate the copper transfer from Hah1 to the MBDs of WDP, an essential process for 
safe trafficking of copper ions in human cells 3, 5-10. Because of the low affinity of the 
Hah1WDP interaction (KD ~ 106 M), their interaction dynamics have been 
challenging to quantify in ensemble measurements. Nanovesicle trapping offers an 
ideal platform to examine their interactions at the single-molecule level using 
smFRET. 
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Figure 2.3. SmFRET control experiments for acceptor blinked/bleached states and the 
dissociated state. (A) Two-color fluorescence intensity trajectories of a nanovesicle 
containing a single Cy3 molecule using 532-nm laser excitation. The Cy3 molecule 
photobleaches at the ~62th second. (B) Two-color fluorescence intensity trajectories 
of a nanovesicle containing a single Cy3 and a single Cy5. The 532-nm laser is on 
throughout; the 637-nm laser was turned on at the ~75th second. The Cy3 
photobleaches at the ~25th second; the Cy5 molecule photobleaches at ~125th second. 
The first 25 seconds mimics the dissociated state of a Cy3-Cy5 pair. (C) Histograms of 
the apparent EFRET (=IA/(IA+ID); ID and IA are the fluorescence intensities of the donor 
and acceptor, respectively) for nanovesicles containing a single Cy3 (line patterned 
columns) and for nanovesicles containing a free Cy3 and a free Cy5 molecule (clear 
columns). 
 
We labeled Hah1 with the acceptor dye Cy5 and MBD4 with the donor dye 
Cy3 using maleimide chemistry at specific cysteine residues, and co-trapped them in 
100-nm diameter nanovesicles. SmFRET trajectories reveal their dynamic interactions 
(Figure 2.4A). These trajectories show three different EFRET states: E0 (~0.2) is the 
dissociated state, and E1 (~0.5) and E2 (~0.8) are two different interaction complexes. 
Transitions between E0 and E1 and between E0 and E2 correspond to the 
binding/unbinding processes for forming complex 1 and 2. The transitions between E1 
and E2 correspond to the interconversions between the two complexes. Figure 2.4B 
gives the interaction scheme between Hah1 and MBD4. The kinetic constants of all 
interaction processes can be extracted by analyzing the distributions of dwell times in 
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each FRET state (Figure 2.4CH, Section 4). The direct observation of the 
interconversion dynamics between the two interaction complexes is particularly 
exciting here, as it enables determination of both the forward and the reverse 
interconversion rate constants (see Section 4) — ensemble characterization often can 
only determine the sum of the forward and reverse rates for intermediate 
interconversion dynamics, as the interconversion dynamics are generally non-
synchronizable. 
 
2.5. Single-molecule kinetic analysis of three-state proteinprotein interactions  
The interaction scheme between Hah1 and MBD4 can be generalized to that in 
Figure 2.5A. An idealized EFRET trajectory showing three FRET states is given in 
Figure 2.5B with different types of dwell times denoted. In this section, we derive the 
probability density functions of the dwell times involved in this three-state interactions 
using single-molecule kinetic analysis 21, 22, 31, 32. 
We first consider the binding processes that occur during the dwell time 0 in 
the E0 state. Based on the interaction scheme in Figure 2.5A, the processes occurring 
during 0 are summarized in Scheme 2.1. The ensemble rate equations for these kinetic 
processes are:  
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Figure 2.4. SmFRET measurements of weak protein interaction dynamics in a 
nanovesicle. (A) Two-color fluorescence intensity (upper) and corresponding apparent 
EFRET (lower) trajectories of a Cy5-Hah1 and a Cy3-MBD4 trapped in a 100-nm 
nanovesicle. (B) Interaction scheme between Hah1 and MBD4. (C-H) Distributions of 
the six types of dwell times from the EFRET trajectories of Hah1MBD4 interactions. 
Solid lines are exponential fits; insets give the exponential decay constants and their 
relations to the protein interaction rate constants in (B). [P] is the effective 
concentration (~3 M) of a single molecule in a 100-nm vesicle. The individual rate 
constants are: k1 = (1.6  0.2)  105 M1s1, k1 = 0.88  0.04 s1, k2 = (1.4  0.2)  105 
M1s1, k2 = 1.3  0.1 s1, k3 = 0.42  0.04 s1, and k3 = 0.7  0.1 s1. Data in (A, C-
H) adapted with permission from reference 21, 22; Copyright 2008 American Chemical 
Society.  
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Figure 2.5. Generic kinetic scheme of protein interactions and corresponding EFRET 
trajectories. (A) Generalized kinetic scheme of a single interacting pair with three 
FRET states: one dissociated state, A + A, with a FRET value of E0; and two 
interaction complexes, B and C, with FRET values of E1 and E2, respectively. (B) 
Idealized three-state EFRET trajectories of an interacting pair; all six types of dwell 
times are denoted. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.1. Kinetic processes occurring during the dwell time 0 at the E0 state. 
 
For the single-molecule reactions occurring in a nanovesicle, we have to consider the 
molecules in terms of their probabilities at time t, P(t). The above rate equations then 
become: 
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Here PA(t) is the probability of finding A at time t; PA(t), PB(t), and PC(t) are defined 
similarly; and PA(t) + PB(t)+ PC(t) = 1. Pv,A,A(t) is the conditional probability at time t 
of finding A within the same infinitesimal volume v where A is located, provided that 
A is found. Pv,A,A(t)  is then 
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Here PA,A(t) is the conditional probability at time t of finding A within the entire 
space of the nanovesicle, provided that A is found; and V is the volume of the 
nanovesicle. Because whenever A is present, A is found, PA,A(t) = 1. Therefore, 
Pv,A,A(t) = 1/V, which is the effective concentration (ceff) of one molecule inside the 
nanovesicle. We then have: 
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The initial conditions for solving these equations are PA(0)= PA(0) = 1, PB(0) = 0, and 
PC(0) = 0 with t = 0 being the onset of each binding reaction. 
 We can then evaluate the probability density f0() of the dwell time 0. The 
probability of finding a particular 0 is f0(); and f0() is equal to the sum of two 
probabilities: (1) the probability of molecule A and A to form B between t =  and  + 
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, which is PB() = k1ceffPA(); and (2) the probability of molecule A and A to 
form C between t =  and  + , which is PC() = k2ceffPA().  In the limit of 
infinitesimal , 
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Using the initial conditions to solve Eqs. 2.4a-c for PA(), we get: 
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 f , as expected. 
 The dwell time 0 can be further separated into two types: one 01 that ends 
with a transition to the E1 state, and the other 02 that ends with a transition to the E2 
state. We can also evaluate the corresponding probability densities f01() and f02() 
of the dwell times 01 and 02. The probability of finding a particular 01 is 
f01(); and f01() is equal to the probability for A and A to form B between t = 
 and  + , which is PB() = k1ceffPA().  The probability of finding a particular 
02 is f02(); and f02() is equal to the probability for A and A to form C 
between t =  and  + , which is PC() = k2ceffPA(). In the limit of infinitesimal 
: 
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Expectedly, f01() + f02() = f0(). Note the exponential decay constants of f01() 
and f02() are the same as that of f0(), all equal to (k1+k2)ceff, the sum of the two 
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parallel kinetic processes in Scheme 2.1. The ratio between the total occurrence N01 
of dwell time 01 and the total occurrence N02 of dwell time 02 in the smFRET 
trajectories also carries important information: 
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 Similarly, we can derive the probability density function of the dwell time 1 
on the E1 state, which can be separated into two types: 10 and 12, and that of the 
dwell time 2 on the E2 state, which can be separated into 20 and 21. The results 
are:  
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  )(exp)( 31101 kkkf       (Eq. 2.7b) 
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 Equations (Eq. 2.6a-d), (Eq. 2.7a-d), and (Eq. 2.8a-d) can be used to fit the 
corresponding experimental results to obtain the rate constants. The Figure 2.4C 
caption gives the determined rate constants for each of the kinetic steps in the Hah1-
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MBD4 interaction, from which the KD’s of the interaction complexes can be 
calculated. In ensemble-averaged measurements, if the two interaction complexes 
cannot be differentiated but are detectable, the measured effective dissociation 
constant (KD,eff) is related to the KD’s of the two complexes as 1/KD,eff = 1/KD1 + 1/KD2. 
 
2.6. Further developments 
A limitation of using Egg PC for forming nanovesicles is the enclosed 
environment that prevents facile exchange of solution. Being able to change the 
solution condition and introduce additional chemical reagents is highly desired, 
however. Ha and coworkers have developed two strategies to make the nanovesicles 
porous to allow exchange of solution into the nanovesicles 20: (1) Using a lipid with a 
higher Tm and performing experiments at its Tm, which induces defects in the lipid 
membrane. (2) Incorporating into the bilayer membrane the bacterial toxin -
hemolysin that forms pores. 
The first strategy is based on the fact that lipid bilayer membranes form 
packing defects at Tm, making the membrane permeable to small molecules 33, 34. Ha 
and coworkers used the lipid DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine), 
which has a Tm of ~23°C. They showed that at ~23C, the nanovesicles made of 
DMPC lipid membranes are permeable to molecules as large as ATP, but not to 
macromolecules such as proteins and DNA. The second strategy uses the natural pore-
forming ability of the membrane protein -hemolysin, a heptameric transmembrane 
channel from Staphylococcus aureus. The monomers of -hemolysin self-assemble 
into the heptameric channel structure in a lipid bilayer, forming a stable pore of 1.4 – 
2.4 nm diameter and allowing exchange of most solution components 35.  
The lipid membrane of the nanovesicles also provides a natural platform for 
studying protein interactions that involve membrane-bound or membrane-anchored 
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proteins. To do so, one can incorporate or anchor one protein to the lipid membrane of 
the nanovesicle and trap the other protein inside. SmFRET measurements can then be 
employed to monitor their interactions at high effective concentrations.  
The confined volume of the nanovesicles can also be exploited to probe the 
crowding effects on protein interactions by co-trapping a larger number of different 
types of unlabeled macromolecules inside, for example polysaccharides. This 
crowding effect arguably mimics the intracellular environment, offering an 
opportunity to study biomacromolecule dynamics in a controlled and confined 
environment in vitro.  
 
2.7. Concluding remarks 
Nanovesicle trapping is a convenient approach to enable single-molecule 
studies at high effective concentrations. This approach also offers easy surface 
immobilization and minimization of nonspecific interactions with glass surfaces. 
Coupled with smFRET measurements, dynamic events of protein interactions with 
weak affinity can be monitored in real-time at the single-molecule level. Single-
molecule kinetic analysis allows extraction of quantitative kinetics of the protein 
interactions, some of which are challenging to quantify with ensemble techniques. The 
lipid membrane also mimics the cellular environment, as well as provides a natural 
platform for studying membrane-bound or membrane–anchored proteins. The 
confined volume can further be exploited to study crowding effects on macromolecule 
dynamics at the single-molecule level. With porous vesicles allowing solution 
exchange, many biological processes can be studied at high effective concentrations in 
situ. We expect that more biological studies using the nanovesicle trapping approach 
will emerge. 
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CHAPTER 3 
Probing transient copper chaperone-Wilson disease protein interactions at the 
single-molecule level with nanovesicle trapping * 
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3.1. Abstract 
Transient metallochaperone-target protein interactions are essential for 
intracellular metal trafficking, but challenging to study at both the ensemble and the 
single-molecule level. Here we report using nanovesicle trapping to enable single-
molecule fluorescence resonance energy transfer (smFRET) studies of transient 
interactions between the copper chaperone Hah1 and the fourth metal-binding domain 
of its target protein, the Wilson disease protein (WDP). We were able to monitor their 
interactions in real time one event at a time, capture distinct protein interaction 
intermediates, resolve intermediate interconversion dynamics, and quantify both the 
interaction kinetics and thermodynamics in the absence of copper. The study 
exemplifies the ability of nanovesicle trapping in combination with smFRET for 
studying weak protein interactions, and provides insight into how Hah1 and WDP may 
collaborate to mediate copper transfer inside cells. 
 
3.2. Introduction 
Metals are essential nutrients that can also be toxic. Safe trafficking of metal 
ions is necessary inside cells, and specific metal transport pathways exist to deliver 
them to their destinations.1-4 In human cells, the copper chaperone Hah1 and the 
Wilson disease protein (WDP) constitute a copper transport pathwayHah1 is a 
single-domain cytoplasmic protein; WDP is a multidomain protein anchored on 
organelle membranes and has a cytosolic N-terminal region consisting of six 
homologous metal-binding domains (MBDs). All WDP MBDs and Hah1 contain a 
conserved CXXC motif that binds Cu1+, and Cu1+ is transferred from Hah1 to a WDP 
MBD via direct and specific Hah1-MBD interactions.1, 2, 5, 6 
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Although the MBDs of WDP have different functional roles,6-9 all of them, as 
well as Hah1, have similar Cu1+ binding affinities.5 This similarity indicates that the 
Hah1 to WDP Cu1+ transfer is under kinetic control mediated by Hah1-WDP 
interactions, and that the functional differences among WDP MBDs are not defined by 
their Cu1+ binding abilities but may be related to how each MBD interacts with Hah1. 
Very limited quantitative information is available, however, on the Hah1-WDP 
interaction dynamics. This is partly because the Hah1-WDP interactions are transient, 
and transient interactions are difficult to quantify in ensemble-averaged experiments. 
Here we report using nanovesicle trapping and single-molecule fluorescence 
resonance energy transfer (smFRET) measurements to probe the transient interactions 
between Hah1 and the fourth MBD (MBD4) of WDP in real time. We chose MBD4 as 
a representative WDP MBD because it is known to interact with Hah1 directly for 
Cu1+ transfer.6, 10, 11 Quantification of Hah1-MBD4 interaction dynamics will help 
understand how Hah1 and the full length WDP interact for Cu1+ transfer. 
 
3.3. Experimental 
3.3.1. Protein engineering, expression, purification, and quantitation  
The Hah1 gene, cloned into a pET21b vector (Novagen),12 was modified via 
site directed mutagenesis to produce a Cys41  Ser mutation (forward primer: 5’-
CCC AAC AAG AAG GTC TCA ATT GAA TCT GAG CAC-3’; reverse primer: 5’-
GTG CTC AGA TTC AAT TGA GAC CTT CTT GTT GGG-3’. The mutations are 
indicated in bold face.) The resulting gene was amplified by PCR using primers 
containing a cysteine inserted at the C-terminal (Cys69) (forward primer: 5’-TAA 
TAC GAC TCA CTA TAG GG-3’; reverse primer: 5’-GGA GCT CGA ATT CTA 
GCA CTC AAG GCC AAG GTA GG-3’. The insertion is indicated in bold face. 
Underlined is the EcoRI restriction site.) and reinserted into an empty pET21b 
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between the restriction sites of EcoRI and NdeI to generate the final Hah1 mutant. 
Cloning was performed in the cell strain NovaBlue or DH5. All mutations were 
confirmed by DNA sequencing (Biotechnology Resource Center, Cornell University).  
 The mutant Hah1 was expressed in BL21(DE3) cells,12 which were grown to a 
optical density of 0.8 – 1.1 at 600 nm and induced with 1 mM IPTG.  Cells were lysed 
via freeze/thaw cycles, and proteins were purified from the lysate via anion exchange 
(HiTrap Q HP), cation exchange (HiTrap SP HP), and gel filtration (HiLoad 26/60 
Superdex 200 prep grade) chromatography using a GE FPLC system. The protein 
purity was determined by SDS-PAGE and the identity was confirmed by mass 
spectrometry. The protein was stored in 20 mM MES, pH 6.0, 150 mM NaCl, 20% 
Glycerol.   
 The wild type MBD4 gene in pET24d6 was amplified by PCR using primers 
containing Cys4  Ser mutation and a C-terminal cysteine insertion (Cys76) 
(Forward primer: 5’-TAG TAG GGC GCG CCA ATG GGC ACA TCG AGT ACC 
ACT C-3’; reverse primer: 5’-ATT TGA GGC TTC AGT CGT TTC TGA ATG CTG 
AAG CTT TAG TAG-3’. The insertion is indicated in bold face. AscI and HindIII 
sites are underlined.) The mutant gene was then cloned between the AscI and HindIII 
restriction sites of a pET24b vector bearing a 15-residue AviTag!TM sequence 
(Avidity)13 inserted between NdeI and HindIII sites,  resulting an AviTag fused to the 
N-terminal of the mutant MBD4. This peptide sequence renders the expression of the 
mutant MBD4 gene, which does not express well alone, and can also be biotinylated 
specifically for immobilization if needed. All mutations were confirmed by DNA 
sequencing. 
 The mutant MBD4 was expressed in Rosetta(DE3) cells as described.6 Briefly, 
cells were grown to an optical density of 0.6 at 600 nm and induced with 0.5 mM 
IPTG. Cells were lysed via freeze/thaw cycles and proteins were purified from the 
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lysate through anion exchange and gel filtration chromatography. The protein purity 
was checked by SDS-PAGE and the identity was confirmed by mass spectrometry. 
The protein was stored in 20 mM MES, pH 6.0, 150 mM NaCl, 20% Glycerol. 
 Protein concentrations were quantified using BCA and Bradford protein assays 
using BSA as a standard (Pierce), and the thiol quantitation method (Molecular 
Probes). Copper concentrations were quantified using a BCA-based method by 
Brenner and Harris and with [Cu(CH3CN)4]PF6 (Aldrich) or copper atomic absorption 
standard solution (Acros Organics) as the standard.14  
 The copper transfer assay was done according to the literature procedures.5, 15, 
16 Briefly, the Cu1+loaded Cy5-Hah1 was mixed with the apo Cy3-MBD4 and 
incubated at room temperature for 30 minutes. Then the proteins were separated using 
anion-exchange chromatography (Amersham Tricorn Mono Q 5/50 GL). We then 
quantitated the protein concentrations by measuring the absorbance of the Cy3 and 
Cy5 labels and using their extinction coefficients. The extinction coefficients of Cy3 
(113,400  800 M1cm1 at 549 nm) and Cy5 (171,000  2000 M1cm1 at 646 nm) 
were determined in the same buffer solution (20 mM MES, 150 mM NaCl, pH 6.0) as 
that for protein samples. 
 
3.3.2. Protein labeling and purification  
Mutant Hah1, at a concentration of 500 µM, was initially treated with 5 mM 
TCEP in 100 mM pH 7.0 phosphate buffer for 30 minutes to fully reduce all disulfide 
bonds. [CuI(CH3CN)4]PF6 was then added to a final concentration of 1 mM and 
incubated for 30 minutes to bind to the metal binding cysteines in the CXXC motif to 
protect these cysteines from labeling. Cy5 maleimide mono reactive dye (Amersham 
Biosciences), in DMSO, was then added to a final concentration of 2 mM (4 
equivalents) and the reaction was incubated for 4 hours at room temperature followed 
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by gentle rocking overnight at 4°C. The reaction was then quenched by adding an 
excess of β-mercaptoethanol (Sigma) and incubated for one hour to ensure all 
unreacted dye was quenched. The reaction mixture was then treated with a ten-fold 
excess of KCN (J.T. Baker) over copper concentration to chelate out most of the Cu1+ 
bound to Hah1. Free dye and CN chelated Cu1+ were removed by size exclusion 
chromatography (Superdex Peptide HR 10/30, Amersham Biosciences). Labeled and 
unlabeled protein species were then separated by anion exchange chromatography 
(Tricorn Mono Q 5/50 GL, Amersham Biosciences). The labeled protein was further 
treated with three cycles of incubation with 200 equivalents of BCA and membrane 
centrifugation filtration to remove the residual protein bound Cu1+.     
 Labeling procedure of the mutant MBD4 with Cy3 was parallel to that for the 
mutant Hah1 with a few exceptions. Instead of protecting the metal binding cysteines 
in the CXXC motif with Cu1+, Hg2+ (Hg(NO3)2) was used. In addition, 12 equivalents 
of Cy3 (6 mM) were added to the protein in small aliquots. We removed Hg2+ bound 
to MBD4 after labeling using three cleaning cycles; each cycle includes incubation 
with 5 equivalents of EDTA followed by membrane centrifugation filtration to 
removed EDTA-Hg2+.  
 
3.3.3. Labeling specificity confirmation  
Labeling specificity was determined by trypsin digestion of the modified 
proteins. The proteins to be digested were mixed in equal amounts with 1:1 tert-
butanol:H2O and heat-denatured for 10 minutes at 65 °C. The solution was then 
diluted 6 times with 50 mM NH4HCO3  pH 7.6. Trypsin (0.1µg/µL) (Roche) was 
subsequently added and incubated for 24 hours at 37 °C. Peptide fragments were then 
buffer exchanged to 70% acetonitrile, 4% acetic acid and 26% H2O for MS analysis. 
The peptide fragments of mutant Hah1 were analyzed by LC-MS (LCMS-QP8000α, 
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Shimadzu). Peptide fragments of mutant MBD4 were analyzed using MALDI mass 
spectrometry at the Protein Structure Facility at University of Michigan. 
 
3.3.4. Nanovesicle trapping  
Nanovesicle trapping was performed following literature  procedures.17-19 A 
mixture of L-α-phosphatidylcholine (eggPC) and 1% 1,2-dipalmitoyl-sn-glycero3-
phosphoethanolamine-N-(cap biotinyl) (16:0 biotinyl cap PE) (Avanti Lipids) in 
chloroform was dried under a constant flow of nitrogen. For preparing the bilayer 
support, lipids were hydrated with standard lipid buffer (10 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 1 mM EDTA) to form multilamellar vesicles at a concentration of 5 
mg/mL total lipids. Protein loaded vesicles were prepared by hydrating the lipid film 
with solutions containing 3 µM Cy5-Hah1, 3 µM Cy3-MBD4, 1 mM Trolox (Sigma), 
and 1 mM TCEP (Sigma) in 20 mM MES, 150 mM NaCl, pH 6.0 buffer, followed by 
seven freeze-thaw cycles to increase the encapsulation efficiency. Protein integrity 
after freeze-thaw cycles was confirmed by circular dichroism spectroscopy. The 
solution was then repeatedly extruded through a polycarbonate membrane with 100 
nm pores (Avanti Mini Extruder) to form 100-nm diameter unilamellar vesicles 
encapsulating proteins. Loaded vesicles were used for experiments immediately or 
within 48 hours from preparation.  
 
3.3.5. Single-molecule experiments  
Single-molecule fluorescence measurements were performed on a homebuilt 
prism-type total internal reflection microscope based on an Olympus IX71 inverted 
microscope. A continuous wave circularly polarized 532 nm laser beam (CrystaLaser, 
GCL-025-L-0.5%) of 1-5 mW was focused onto an area of ~150 75 m2 on the 
sample to directly excite the Cy3 probe. To directly excite Cy5 fluorescence, a linearly 
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polarized 637 nm laser (CrystaLaser) was used. The fluorescence of Cy3 and Cy5 was 
collected by a 60X NA1.2 water-immersion objective (UPLSAPO60XW, Olympus), 
filtered to reject laser light (HQ550LP), and split by a dichroic mirror (635DCXR) 
into two channels using a Dual-View® system (Optical Insights, Inc). Each channel of 
fluorescence was further filtered (HQ580-60m or HQ660LP) and projected onto half 
of the imaging area of a camera (Andor iXon EMCCD, DV887DCS-BV), controlled 
by an Andor IQ software. All optical filters are from Chroma Technology Corp. 
Single-molecule fluorescence images and movies were taken with the Andor-IQ 
software. 
 A flow cell, formed by double-sided tape placed between a quartz slide 
(Technical Glass or Finkenbeiner) and a boronsilicate coverslip (Gold Seal®), was 
used to hold aqueous sample solutions for single-molecule fluorescence 
measurements. All samples were in 20 mM MES, pH 6.0, 150 mM NaCl unless 
indicated otherwise. To form the bilayer support, unloaded vesicles were flowed in at 
5 mg/mL (500 L) and incubated for 1 to 2 hours. Excess lipids were washed away 
with standard lipid buffer. Alternatively, the slides were first amine-functionalized 
(Vectabond, Vector Laboratories) and then coated with PEG polymers (100 mg/mL 
m-PEG-SPA-5000 and 1 mg/mL biotin-PEG-NHS-3400, Nektar Therapeutics).20, 21 
1% of the PEG polymers contain a biotin terminal group to form biotin-streptavidin 
(Molecular Probes) linkages. 500 L of streptavidin at a concentration of 0.2 mg/mL 
was then flowed in and incubated for 10 minutes. Unbound streptavidin was then 
washed out with buffer containing 0.1 mg/mL BSA, which help to block nonspecific 
binding sites.22 Protein-loaded vesicles were flowed in at a total protein concentration 
of 30 pM and unbound vesicles were then washed out before single-molecule imaging 
experiments. An oxygen scavenging system (0.1 mg/mL glucose oxidase (Sigma), 
0.025 mg/mL catalase (Roche), 4% glucose (Aldrich)) and 1 mM Trolox (Sigma)23 
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was added into the sample solution just before each experiment to prolong the lifetime 
of the fluorescence probes, and was refreshed during experiments every half an hour. 
 
3.4. Results and analysis 
A primary obstacle in single-molecule experiments to probe transient protein 
interactions is the low concentrations (1012-109 M) commonly used to spatially 
separate molecules for detection, which limits the experiments to strong protein 
interactions. Weak protein interactions, including Hah1-WDP interactions, need to be 
studied at higher concentrations. Nonspecific protein-glass surface interactions during 
molecule immobilization present another challenge, and must be minimized. 
To overcome these challenges, we adapted a nanovesicle trapping strategy, 
which was used to study protein and RNA folding and DNA-protein interactions at the 
single-molecule level.19, 24 We trapped the two interacting molecules in a 100-nm- 
diameter lipid vesicle. Because of the confined volume (~51019 L), the effective 
concentration is ~3 M for each protein inside. Low concentrations of vesicles are 
then immobilized on a lipid bilayer or polymer coated glass surface so protein-glass 
interactions are eliminated. 
To report Hah1-MBD4 interactions by smFRET, we introduced a C-terminal 
cysteine in both Hah1 and MBD4 and labeled this cysteine of Hah1 with Cy5 and that 
of MBD4 with Cy3. Cy3-Cy5 form a FRET pair with a Förster radius of ~6 nm. The 
cysteines in the CXXC motifs were protected specifically from labeling. We purified 
the labeled proteins and confirmed their Cu1+ binding and transfer functions (see 
Supporting Information (SI)). 
We used total internal reflection fluorescence microscopy with 532-nm laser 
excitation to measure smFRET of single interacting pairs of Cy5-Hah1 and Cy3-
MBD4 trapped in nanovesicles. We only analyzed data from vesicles containing one 
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Cy5-Hah1 and one Cy3-MBD4 (see SI). This way we also eliminated the complication 
of dimeric or multimeric interactions between molecules of the same type, which are 
unavoidable in ensemble experiments and complicate protein-interaction studies. This 
is particularly relevant in studying Hah1-WDP interactions, as Hah1 could form 
homodimers.12  
The fluorescence and the corresponding FRET efficiency (EFRET) trajectories 
of two interacting pairs of Hah1 and MBD4 molecules are shown in Figure 3.1A and 
3.1B. The Cy3 and Cy5 fluorescence of each pair show anticorrelated intensity 
fluctuations, reporting transient Hah1-MBD4 interactions. Three EFRET states are clear 
in the EFRET trajectories at EFRET ~0.2, 0.5, and 0.9, denoted as E0, E1 and E2, 
respectively. E0 is clearly different from that (<0.1) of the acceptor photobleached or 
blinked state. Considering the small dimensions of Hah1 and MBD4 (2~3 nm),6, 12, 25 
the small value of E0 indicates Hah1 and MBD4 are distant from each other; we thus 
associated E0 with their dissociated state (see section 3.4.1). The values of E1 and E2 
indicate the two proteins are within a few nanometers in these two states; we thus 
associated E1 and E2 with two transient Hah1-MBD4 interaction complexes (see 
section 3.4.1 and Figure 3.3). The significant difference between E1 and E2 indicate 
the Cy3-Cy5 distances differ by nanometers between the two complexes, which can 
arise from their differences in overall interaction geometries or in the conformation of 
one or both proteins. The latter is less likely as NMR studies showed Hah1 only has 
angstrom-scale conformational flexibilities,26 which should not result in significant  
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Figure 3.1. Single-molecule trajectories, interaction scheme and dwell-time 
distributions. (A), (B) Fluorescence and EFRET (= ICy5/(ICy3+ICy5)) trajectories of two 
interacting Cy5-Hah1 and Cy3-MBD4 pairs. (C) Hah1-MBD4 interaction scheme. (D) 
Waiting time () distributions for the six kinetic steps in (C). Data compiled from 163 
Hah1-MBD4 interacting pairs and total 1101 transitions. Solid lines are exponential 
fits. 
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difference in EFRET that is sensitive only at the nanometer scale. The NMR structure of 
the fourth MBD of the Wilson protein has only angstrom–scale conformational 
flexibility as well.27 The direct resolution of two distinct interaction complexes here is 
the first evidence that multiple interaction intermediates exist for metallochaperone-
target protein interactions and that Hah1 can form complexes with WDP without Cu1+. 
We have further confirmed that nonspecific interactions between the proteins and the 
lipids are minimal and the protein interactions are not induced by the labeling (see SI). 
In the EFRET trajectories, the transitions between E0 and E1 and between E0 and 
E2 reflect the Hah1-MBD4 association and dissociation events, while those between 
E1 and E2 are the interconversions between the two interaction complexes. Figure 3.1C 
shows the Hah1-MBD4 interaction scheme deduced from the smFRET data. The six 
rate constants in the scheme are obtainable from the statistical distributions of the six 
types of waiting times before each EFRET transition (Figure 3.1D; see SI). All waiting 
time distributions can be fitted with single-exponential decays. For Hah1-MBD4 
complex dissociations and interconversions, which are unimolecular reactions, the rate 
constants can be obtained from the decay constants of the E1 and E2 dwell-time 
distributions. For protein association, the effective concentration (~3 M) of a 
molecule in a nanovesicle needs to be factored out from the decay constants to obtain 
the combination of rate constants. The determined rate constants are ~100 s1 for 
complex dissociations and interconversions, and ~105 M1s1 for protein associations 
(Figure 3.1D). Particularly, we have directly resolved the interconversion dynamics 
between the two interaction complexes and quantified the rate constants of both the 
forward and the reverse reactionsensemble studies of intermediate interconversion 
dynamics typically only obtain the sum of the forward and reverse rate constants. The 
rate constants also enabled determination of separate dissociation constants for the two 
interaction complexes with K1 = 5.60.6 M and K2 = 91 M (see also Figure 3.2).  
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 Figure 3.2 shows the compiled histograms of EFRET trajectories of many 
interaction pairs of Cy3-MBD4 and Cy5-Hah1. The histogram shows three peaks at 
~0.2, 0.5, and 0.9, corresponding to E0, E1, and E2, respectively. The relative areas of 
these three peaks represent the relative stability of the dissociated state, complex 1, 
and complex 2; the calculated dissociated constants are K1 ~5  1 M and K2 = 8  2 
M, consistent with those calculated from the kinetic constants (Figure 3.1D). 
 
3.5. Discussion 
The ability of Hah1 and MBD4 to form multiple interaction complexes with 
different interaction geometries has functional significance. First, it increases the 
probability of complex formation when Hah1 and WDP encounter through diffusion 
inside cells. The formed complex may proceed to accomplish Cu1+ transfer, or, if 
unproductive, convert to another complex for Cu1+ transfer. Second, it raises the 
possibility of Hah1 interacting with two WDP MBDs simultaneously and hence 
cooperative effects among WDP MBDs for Cu1+ transfer. The interactions of Hah1 
with different combinations of MBDs may also play a role in the functional 
differences of these MBDs.  
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Figure 3.2. Compiled histogram of EFRET trajectories of Hah1-MBD4 interacting pairs 
(163 trajectories), showing three peaks corresponding to E0, E1, and E2 states. The 
solid lines are fits with three Gaussian functions centered at ~0.16 ± 0.15, 0.55 ± 0.12, 
0.84 ± 0.12 (the errors here are standard deviations). The relative areas of these three 
peaks represent the relative stabilities of the dissociated state, complex 1, and complex 
2; the calculated dissociation constants are K1 ~5 ± 1 μM and K2 = 8 ± 2 μM, 
consistent with those calculated from the kinetic constants. The trajectories are 
truncated at the photobleaching step of either label.  
  
3.5.1. Further discussions of the EFRET states for Hah1-MBD4 interactions 
 The control experiments using Cy5-Hah1 with free Cy3 and using Cy3-MBD4 
with free Cy5 co-trapped in a nanovesicle also provide references for the Hah1 and 
MBD4 dissociated state. For both control experiments, the EFRET values obtained from 
the fluorescence trajectories are ~0.17, same as E0 (see Figure 3.2 above). This 
confirms that E0 is the dissociated state of Hah1 and MBD4. 
 As further controls and to calibrate the apparent EFRET values (approximated as 
ICy5/(ICy5+ICy3)), we used the data from our single-molecule FRET studies of a DNA 
Holliday junction.28 This DNA Holliday junction has two stacked conformations at 
dynamic equilibrium with each other. With Cy3 and Cy5 labeled at specific locations, 
these two stacked conformations give rise to two EFRET states due to their different 
Cy3-Cy5 distances.28 Using a crystal structure of Holliday junction29 and standard 
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DNA structural parameters, we obtained the distances between the attachment points 
of Cy3 and Cy5 for both conformations. The obtained EFRET versus Cy3-Cy5 distances 
are plotted in Figure 3.3, and fitted with the scaled EFRET equation EFRET = c/[1+(rD-
A/r0)6] used by Meller and coworkers for calibrating single-molecule FRET studies 
with Cy3-Cy5 probes.30 Here c is a scaling factor accounting for the contributions to 
the apparent EFRET by non-FRET processes, including detection channel cross-talks, 
residual direct excitation of the acceptor, and detection efficiencies of the two 
channels. rD-A here is the distance between the attachment points of the Cy3 and Cy5 
labels. 
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Figure 3.3. EFRET calibration. The reference data points are taken from reference.28 
Black solid line is a fit with the equation EFRET = c/[1+(rD-A/r0)6] (c = 0.71 and r0 = 6.4 
nm). The vertical red line marks the maximum possible D-A distance in an Hah1-
MBD4 complex.     
 
 Based on this calibration (Figure 3.3), E0 (~0.17) corresponds to rD-A ~7.8 nm, 
significantly larger than the maximum dimension possible for a Hah1-MBD4 
complex. (Using the crystal structure of Hah1 and a homology model of MBD4 
(Figure S1),12, 25 the maximum edge-to-edge distance of a possible Hah1-MBD4 
complex is ~6.8 nm.) This further supports that E0 is the dissociated state of Hah1 and 
MBD4. Similarly, E1 (~0.55) corresponds to rD-A ~5.2 nm. For E2 (~0.87), as its value 
 65 
is outside the bounds of our reference points and the FRET technique is known to not 
be sensitive in the short distance regime, determination of its corresponding rD-A is 
unreliable; instead, we obtained an upper bound, i.e., rD-A < 3.3 nm (rD-A ~ 3.3 nm 
corresponds to EFRET ~0.7). The small rD-A’s of E1 and E2 are consistent with the 
assignment that they are two Hah1-MBD4 interaction complexes. Moreover, the 
difference between the rD-A of E1 and that of E2 is >19 Å. This difference is less likely 
from mere conformational differences of Hah1 or MBD4 in these two complexes, as 
Hah1 and MBD4 only have conformational flexibility of a few angstroms from NMR 
studies25, 26 We thus suggest that E1 and E2 are two Hah1-MBD4 complexes with 
different interaction geometries.  
 
3.6. Summary 
In summary, this study represents the first application of nanovesicle trapping 
to study weak protein-protein interactions on a single-molecule basis. We observed 
transient copper chaperone-target protein interactions one event at a time, captured 
distinct protein interaction intermediates, and resolved intermediate interconversion 
dynamics. The quantitative dynamic information will help understand how 
metallochaperones and their target proteins collaborate for metal transfer. By studying 
the Cu1+ dependence of the interaction kinetics, this single-molecule approach also 
offers a means to probe the Cu1+ transfer process and identify the productive 
interaction complex. Moreover, we expect that the nanovesicle trapping strategy 
coupled with smFRET is applicable for studying many other weak protein interactions 
at the single-molecule level 
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SUPPORTING INFORMATION 
 
S.1. Protein mutations  
 Both Hah1 and MBD4 have three cysteines: two in the conserved CXXC 
motifs that bind Cu1+ and a nonessential third. We mutated the nonessential cysteine to 
serine and introduced a C-terminal cysteine in both proteins for specific labeling. The 
mutation sites and the labeling locations are distant from the Cu1+ binding CXXC 
motifs in both proteins, and they thus should not interfere with the Cu1+ binding of the 
proteins (Figure S1). The identities of the mutant proteins were confirmed by mass 
spectrometry (Figure S2). 
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Figure S1. Protein models. (A) Crystal structure of wild type Hah1.12 (B) A homology 
model of WDP MBD4 structure based on the NMR structure of the fourth metal 
binding domain of the Menkes protein.25 The engineering locations, labeling sites, and 
the conserved Cu1+ binding CXXC motif are marked. 
 
S.2. Protein labeling and labeling specificity confirmation  
 We labeled the mutant Hah1 and MBD4 at the C-terminal cysteines with Cy5 
and Cy3 respectively, using maleimide chemistry. We protected the metal binding 
cysteines in the CXXC motif of Hah1 from labeling by addition of Cu1+, and those of 
MBD4 by addition of Hg2+. We then removed Cu1+ using CN and BCA as chelators, 
and removed Hg2+ using EDTA. The complete removal of Cu1+ from Hah1 was 
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Figure S2. Mass spectra of mutant Hah1 (A) and MBD4 (B). The numbers in the 
parentheses are expected values. The side peaks in B are due to sodium adducts. 
 
verified by the BCA copper quantitation assay (lower than the detection limit, 
corresponding to less than 1% copper content), and the complete removal of Hg2+ 
from MBD4 was confirmed (less than 1%) by the absence of the thiolate  Hg2+ 
charge transfer transition at 250 nm in the UV-Vis spectra (Figure S3).31, 32   
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Figure S3. Hg2+ binding. (A) UV-Visible spectra monitoring the appearance of the 
thiolate  Hg2+ charge transfer band upon titrating 40 μM MBD4 with excess 
Hg(NO3)2. The absorbance of the free protein, free Hg(NO3)2, and buffer were 
subtracted from the spectra. (B) The absorbance (at 250 nm) titration curve derived 
from (A). This titration curve was used to calculate the percentage of protein-bound 
Hg2+ and confirm Hg2+ removal by EDTA.   
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 The singly labeled proteins were separated cleanly from the unlabeled proteins 
using anion-exchange chromatography (Figure S4). The total masses of Cy5-Hah1 and 
Cy3-MBD4 suggest the presence of a single label (Figure S5A and C). We confirmed 
their labeling specificity at the C-terminal cysteines using trypsin digestion and mass 
spectrometry. The masses of their C-terminal fragments indicate the addition of the 
Cy5/Cy3, as expected (Figure S5B and D). 
 
 
Figure S4. Anion exchange chromatography of purification of Cy5-Hah1 (A) and 
Cy3-MBD4 (B). 
 
 
Figure S5. MS spectra. ESI-MS spectra of Cy5-Hah1 (A), and its trypsin digested C-
terminal fragment with Cy5 (B). Multiply charged ions are indicated. MALDI spectra 
of Cy3-MBD4 (C) and its trypsin digested C-terminal fragment with Cy3 (D). 
Expected masses in parentheses. 
 
 70 
S.3. Confirmation of Cu1+ binding and transfer function of labeled Hah1 and 
MBD4 
 We confirmed the Cu1+ binding and transfer capabilities of the labeled Hah1 
and MBD4 (see Materials and Methods). The copper-to-protein ratio of a Cu1+-loaded 
Cy5-Hah1 was found to be 0.92 ± 0.08, slightly higher than the reported literature 
values of 0.85 ± 0.10 and 0.68 ± 0.12,5, 33  and that of Cy3-MBD4 was 1.28 ± 0.16, 
also slightly higher than the reported literature value of 0.84.15 The equilibrium 
constant for Cu1+ transfer from Cy5-Hah1 to Cy3-MBD4, Kex, was found to be 2 ± 1, 
slightly lower than the 5.4 ± 0.3 value of Cu1+ transfer between wild type Hah1 and 
the fourth MBD within a six-domain construct of WDP.5  
 
S.4. Single-molecule control experiments 
 In preparation of the nanovesicles encapsulating proteins, we adjusted the 
protein/lipid ratio to ensure statistically that most of the vesicles contain only one 
protein molecule and only a small percentage of vesicles contain two protein 
molecules. We used 532-nm excitation to directly image the Cy3-MBD4 and 637-nm 
excitation to directly image Cy5-Hah1. By counting the photobeaching steps in Cy3 or 
Cy5 fluorescence signal, we confirmed that the number of vesicles containing more 
than two molecules (either Cy3-MBD4 or Cy5-Hah1) is negligible. In our smFRET 
measurements, we only use 532-nm excitation, and we select out vesicles that only 
contain one Cy3-MBD4 and that there is a simultaneous Cy5-Hah1 signal from 
FRETbecause of the average vesicle occupation number, the probability that there is 
another Cy5-Hah1 in the same vesicle is negligible. 
 We performed control experiments to check if Cy5-Hah1 and Cy3-MBD4 have 
nonspecific interactions with the lipid membrane. We coated the glass surface with a 
lipid bilayer in the sample cell and flowed in solutions containing up to 100 nM free 
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Cy5-Hah1 or Cy3-MBD4. We then washed the sample cell with fresh buffer and 
imaged the Cy5 and Cy3 fluorescence with 637 nm and 532 nm excitations 
respectively. The number of single Cy5-Hah1 or Cy3-MBD4 molecules that are 
immobilized on the lipid bilayer by nonspecific interactions is less than 10 in a typical 
experiment. In contrast, the number of immobilized single molecules of Cy5-
Hah1/Cy3-MBD4 is about 150-250, using the nanovesicle trapping and 
immobilization via biotin-streptavidin linkages at a total protein concentration of only 
30 pM. We thus concluded the nonspecific interactions between Cy5-Hah1/Cy3-
MBD4 and the lipid membrane is insignificant. 
 To check if the observed dynamic interactions between Cy5-Hah1 and Cy3-
MBD4 are induced by the fluorescent labels, we trapped Cy5-Hah1 with free Cy3 or 
Cy3-MBD4 with free Cy5 in nanovesicles in the same way as we co-trapped Cy5-
Hah1 and Cy3-MBD4 in the nanovesicles. In either case, we did not observe anti-
correlated Cy3-Cy5 fluorescence intensity fluctuations like those of Cy5-Hah1 and 
Cy3-MBD4 interactions, and the dynamic Hah1-MBD4 interactions observed in our 
single-molecule experiments are thus not due to dye-dye interactions. 
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CHAPTER 4 
Relating dynamic protein interactions of metallochaperones with metal transfer 
at the single-molecule level * 
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4.1. Abstract 
Metallochaperones undertake specific interactions with their target proteins to 
deliver metal ions inside cells. Understanding how these protein interactions are 
coupled with the underlying metal transfer process is important, but challenging 
because they are weak and dynamic. Here we use a nanovesicle trapping scheme to 
enable single-molecule FRET measurements of the weak, dynamic interactions 
between the copper chaperone Hah1 and the fourth metal binding domain (MBD4) of 
WDP. By monitoring the behaviors of single interacting pairs, we visualize their 
interactions in real time in both the absence and the presence of various equivalents of 
Cu1+. Regardless of the proteins’ metallation state, we observe multiple, 
interconverting interaction complexes between Hah1 and MBD4. Within our 
experimental limit, the overall interaction geometries of these complexes appear 
invariable, but their stabilities are dependent on the proteins’ metallation state. In 
apoholo Hah1MBD4 interactions, the complexes are stabilized relative to that 
observed in the apoapo interactions. This stabilization is undiscernible when Hah1’s 
Cu1+-binding is eliminated or when both proteins have Cu1+ loaded. The nature of this 
Cu1+-induced complex stabilization and of the interaction complexes are discussed. 
These Cu1+-induced effects on the Hah1MBD4 interactions provide a step toward 
understanding how the dynamic protein interactions of copper chaperones are coupled 
with their metal transfer function. 
 
4.2. Introduction 
 Metals are essential for life processes, such as oxygen transport, electron 
transport, and hormone production.1 They can also be toxic, however, especially at 
high concentrations. To maintain normal metabolism, a variety of protein machineries 
control the concentrations and availability of metal ions inside cells.2-4 One type of 
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such protein machineries mediate intracellular metal trafficking, so the metal ions can 
reach their functional locations while avoiding adventitious binding by many other 
possible molecules inside cells.2, 4-8 Intracellular copper trafficking is mediated by 
copper chaperones; they bind and deliver copper to their target proteins through 
specific and dynamic proteinprotein interactions.5, 6, 8-10 In human cells, the copper 
chaperone Hah1 (also called Atox1) delivers Cu1+ to the Wilson disease protein (WDP, 
also called ATP7B) or the Menkes disease protein (MNK, also called ATP7A), for 
subsequent incorporation into copper-requiring enzymes or for efflux under copper 
stress.11-14  
 Hah1 is a small single-domain cytoplasmic protein;6 WDP and MNK are large, 
multidomain proteins anchored on organelle membranes.13, 15-18 The cytosolic N-
termini of WDP and MNK both have six metal-binding domains (MBDs). All these 
MBDs, as well as Hah1, share the same  protein fold and all have the surface 
exposed, conserved CXXC motif, where the two cysteines bind Cu1+. Upon 
Hah1MBD interaction, Cu1+ can be transferred via a thiol ligand exchange 
mechanism at the protein interaction interface.5, 9, 13, 19-21 
 Past studies have shown that the N-terminal MBDs of WDP and MNK have 
different functional roles,13, 22-32 even though all these MBDs, as well as Hah1, have 
similar Cu1+ binding affinities.17, 27, 33-35 This similarity indicates that the Cu1+ transfer 
between them is under kinetic control mediated by protein interactions and that the 
functional differences among WDP (or MNK) MBDs are not defined by their Cu1+ 
binding affinity but may be related to how each MBD interacts with Hah1. 
Quantifying how Hah1 and WDP/MNK MBDs interact is thus crucial for 
understanding their interaction mediated copper transfer process. 
 Yet few quantitative measurements are available, especially on the dynamics of 
protein interactions of copper chaperones.36 This scarcity comes mainly from the 
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difficulty of conventional ensemble measurements of weak protein interactions. These 
weak interactions are dynamic and stochastic, making synchronization of molecular 
actions necessary. Often the steady-state concentrations of interaction intermediates 
are low, making detection difficult. Furthermore, multiple interaction intermediates, if 
present, convolute the ensemble-averaged measurements. 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Protein-protein interactions within a nanovesicle. (A) Schematic of 
nanovesicle trapping of Cy5-Hah1 and Cy3-MBD4 for smFRET studies. The inner 
diameter of the nanovesicle is 80 ± 20 nm. The glass surface is coated with 
biotinylated lipid bilayer, PEG, or BSA to prevent vesicle rupture. (B) Interaction 
scheme between apo-forms of Hah1 and MBD4. Besides the dissociated state, there 
are two interaction complexes that interconvert dynamically. k’s are rate constants. k1 
and k2: ~105 M1s1; k1, k2, k3, and k3: ~100 s1.37, 38 
  
 Our group has used single-molecule fluorescence resonance energy transfer 
(smFRET) to study the dynamic interactions of copper chaperones (Figure 4.1A).36-39  
At the single-molecule level, no synchronization of molecular actions is necessary; 
molecular actions are followed in real time, including the formation and dissociation 
of interaction intermediates; and at any time point, only one molecular state is 
observed. We have initially focused on the interactions between Hah1 and a single 
MBD of WDP (the fourth MBD, MBD4). We label the two interacting proteins with a 
FRET donoracceptor pair and excite the donor directly with a laser while monitoring 
the fluorescence intensities of both the donor (ID) and the acceptor (IA) simultaneously. 
The donor-to-acceptor FRET efficiency can be determined (EFRET  IA/(IA+ID)), which 
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is directly correlated with the donoracceptor interdistance, r, as EFRET = 1/[1+(r/r0)6], 
where r0 is the Förster radius of the donoracceptor pair. Changes in EFRET thus 
directly reflect the changes in the donoracceptor interdistances and thus the protein 
interactions that cause these interdistance changes.  
There are still technical challenges to overcome before smFRET can be applied 
to follow weak protein interactions in real time. The primary challenge is the 
concentration limit: single-molecule measurements are typically performed at pMnM 
concentrations of fluorescently labeled species to separate them spatially. Weak 
protein interactions, including those of copper chaperones with KD ~ M, need to be 
studied at much higher concentrations (> M) to favor complex formation. Moreover, 
to follow the same protein molecules interacting in real time, they need to be surface 
immobilized, where their nonspecific interactions with surfaces must be minimized. 
 We have used a nanovesicle trapping scheme40-42 to overcome the above two 
challenges (Figure 4.1A).37-39 Because of the confined volume (~1019 L) of a 
nanovesicle, each molecule of an interacting pair inside has an effective concentration 
of a few M (see Experimental Section). The overall number of nanovesicles is kept 
low to separate them spatially to ensure single-nanovesicle (i.e., single-pair) detection. 
The nanovesicles are then immobilized on the surface, where possible nonspecific 
interactions of the proteins with the glass surface are eliminated. Although we cannot 
ensure that every nanovesicle will contain two different protein molecules, we can 
control the statistical distribution of molecules in nanovesicles, and for each 
nanovesicle, the number and type of molecules inside can be determined from their 
photobleaching events.37, 39 By examining only the nanovesicles containing two 
different molecules, we can eliminate interactions between molecules of the same type, 
which is not possible in ensemble experiments and significantly complicates protein 
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interaction studies. This complication is particularly relevant for copper chaperones, as 
they can form dimers in solution.43 
 Using the nanovesicle trapping scheme combined with smFRET measurements, 
we have observed real-time interaction events between a single pair of Hah1 and WDP 
MBD4.37, 38, 44 More important, we have identified that even in the absence of Cu1+, 
Hah1 and MBD4 can form two interaction complexes, which interconvert dynamically 
(Figure 4.1B). One complex has an EFRET value of ~0.5 (E1), the other of ~0.8 (E2), 
besides their dissociated state (E0 ~0.2). The significant difference in the EFRET values 
of these two complexes further suggests that they likely have different overall 
interaction geometries. The results have also enabled us to quantify the kinetics of 
association, dissociation, and interconversion of the two interaction complexes, as well 
as their dissociation constants. 
 The existence of multiple interaction complexes between Hah1 and a WDP 
MBD has functional implications. Inside cells, copper chaperones encounter their 
target proteins through diffusion. The initial encounter pair often rapidly returns to the 
dissociated form. The ability to form multiple interaction complexes with different 
geometries increases the probability of complex formation. The formed complex, if 
productive, may proceed to accomplish Cu1+ transfer, or, if unproductive, can convert 
to the other complex for Cu1+ transfer. The interconversion kinetics of Hah1MBD4 
complexes are comparable to their dissociation kinetics (k3 and k3 versus k1 and k2, 
Figure 4.1B), further supporting this possible mechanism of operation.  
 Still, many questions remain. For example, how are the Hah1MBD 
interactions coupled with the Cu1+ transfer process? Of the two interaction complexes, 
which one is productive for metal transfer, or are both so? Do Hah1 and a WDP MBD 
still form multiple complexes in the presence of Cu1+? To address these questions, 
observing Cu1+ transfer directly during protein interaction would be ideal, but is 
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challenging because the d10 electron configuration of Cu1+ makes it magnetically silent 
and optically invisible except for x-ray-based techniques. Our smFRET measurements 
cannot directly observe Cu1+ transfer, either. Nevertheless, as we are able to study the 
protein interactions in real time and quantitatively, we can examine the effects of Cu1+ 
on the interaction dynamics between Hah1 and a WDP MBD. Changes in the protein 
interaction dynamics should inform how the copper chaperone interactions are 
coupled with the underlying Cu1+ transfer process. Here we report our initial results 
along this line. We show how Cu1+ affects the formation and stability of Hah1MBD4 
interaction complexes and how the effects are related to the Cu1+ binding ability of 
Hah1. 
 
4.3. Experimental 
4.3.1. Protein expression, purification, labeling, and mutation.  
Hah1 and WDP MBD4 were expressed, purified, and labeled as previously 
described.37 Both proteins have a C-terminal cysteine introduced via site-directed 
mutagenesis for labeling with a fluorescent probe using maleimide chemistry. Hah1 is 
labeled with the FRET acceptor Cy5 at Cys69, and MBD4 is labeled with the FRET 
donor Cy3 at Cys76. The Cu1+-binding cysteines in Hah1 and MBD4 are protected 
from labeling by coordinating to Cu1+ or Hg2+, which can be removed afterwards using 
BCA or CN (for Cu1+) and EDTA (for Hg2+) as chelators. 
 The mutant Hah1, mHah1, has the two Cu1+-binding cysteines in its CXXC 
motif (Cys12 and Cys15) mutated to serines to eliminate its Cu1+ binding. The 
mutation was confirmed by DNA sequencing and MALDI mass spectrometry of the 
purified protein product (MW: calculated,7325.3 Da; observed, 7325.0 Da). 
 Protein concentrations were quantified using the BCA and Bradford assays 
with BSA as a standard (Pierce), and the thiol quantitation method (Molecular Probes). 
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Copper concentrations were quantified using a BCA-based method by Brenner and 
Harris45 and a copper atomic absorption standard solution (Acros Organics).  
 
4.3.2. Nanovesicle trapping.  
Nanovesicle trapping was performed as previously described.37, 39 A mixture of 
L-α-phosphatidylcholine (eggPC) and 1% 1,2-dipalmitoyl sn-glycero3-
phosphoethanolamine-N-(cap biotinyl) (16:0 biotinyl cap PE) (Avanti Lipids) in 
chloroform was dried under a constant flow of nitrogen. Protein-loaded vesicles were 
prepared by hydrating the lipid film with solutions containing 3 μM Cy5-Hah1, 3 μM 
Cy3-MBD4, 1 mM Trolox (Sigma), and 1520 M TCEP (Sigma) in 60 mM MES, 
110 mM NaCl, pH 6.0 buffer, followed by seven freeze-thaw cycles to increase the 
encapsulation efficiency. Protein integrity after freeze-thaw cycles was confirmed by 
circular dichroism spectroscopy. The solution was then repeatedly extruded through a 
polycarbonate membrane with 100 nm pores (Avanti Mini Extruder) to form 
approximately 100-nm diameter unilamellar vesicles encapsulating proteins. Loaded 
vesicles were used for experiments immediately or within 48 hrs from preparation.  
 To prepare the copper-loaded proteins, the proteins were first incubated for 30 
min with 1520 M TCEP to reduce the proteins, followed by 1 hr incubation with 
appropriate equivalents of Cu1+ ([Cu(CH3CN)4]PF6 (Aldrich) in 50% acetonitrile). The 
solution was then used to hydrate the dry lipid film and incubated for 1 hr for 
nanovesicle encapsulation.  
 The size of the nanovesicles was measured to be 90 ± 20 nm by dynamic light 
scattering (Malvern Zetasizer Nano-ZS; the error bar here is the standard deviation). 
Taking into account the lipid bilayer thickness of ~5 nm,46 the resulting nanovesicles 
have an inner diameter of 80 ± 20 nm. The corresponding effective concentration for a 
single molecule trapped inside is thus 6 ± 5 M. 
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4.3.3. Single-molecule FRET measurements.  
Single-molecule FRET measurements were performed on a homebuilt prism-
type total internal reflection microscope as described previously.38 Briefly, a 
continuous wave circularly polarized 532 nm laser beam was used to directly excite 
the Cy3 probe. The fluorescence of Cy3 and Cy5 was collected, filtered to reject laser 
light, and split into two wavelength channels. Each channel of fluorescence was 
further filtered and projected onto half of the imaging area of a camera, operating at 
50-200 ms frame rate. At 30 seconds prior to the end of data collection, the sample 
was illuminated with a 637 nm laser to directly excite the Cy5 fluorescence for 
determining its number within nanovesicles.39 Single-molecule fluorescence intensity 
trajectories were extracted from the recorded movie, from which the EFRET trajectories 
were calculated. Only the portions of the trajectories during 532 nm laser illumination 
and before the photobleaching events of the probes were analyzed. 
 A flow cell, formed by double-sided tape placed between a quartz slide and a 
coverslip, was used to hold aqueous sample solutions for single-molecule fluorescence 
measurements. All samples were in 60 mM MES, pH 6.0, 110 mM NaCl, 1520 M 
TCEP unless indicated otherwise. The TCEP was present to ensure a reducing 
environment to prevent air oxidation of Cu1+. To form the bilayer support,37, 39 
unloaded vesicles were flowed in at 5 mg/mL (500 L) and incubated for 1 to 2 hours. 
Excess lipids were washed away with standard lipid buffer. Alternatively, the slides 
were first amine-functionalized (Vectabond, Vector Laboratories) and then coated with 
PEG polymers (100 mg/mL m-PEG-SPA-5000 and 1 mg/mL biotin-PEG-NHS-3400, 
Nektar Therapeutics).39, 47 1% of the PEG polymers contain a biotin terminal group to 
form biotin-streptavidin (Molecular Probes) linkages. We also used biotinylated BSA 
to coat the quartz surface:39 a solution of 1 mg/mL biotinylated BSA was incubated on 
the quartz slide for 30 min to 1 hr. Excess biotinylated BSA was then washed out with 
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buffer. 500 L of streptavidin at a concentration of 0.2 mg/mL was then flowed in and 
incubated for 10 minutes. Unbound streptavidin was then washed out with buffer 
containing 0.1 mg/mL BSA, which help to block nonspecific binding sites.48 Protein-
loaded vesicles were flowed in at a total protein concentration of 30 pM and unbound 
vesicles were then washed out before single-molecule imaging experiments. An 
oxygen scavenging system (0.1 mg/mL glucose oxidase (Sigma), 0.025 mg/mL 
catalase (Roche), 4% glucose (Aldrich) and 1 mM Trolox (Sigma)49 was added into 
the sample solution just before each experiment to prolong the lifetime of the 
fluorescence probes, and was refreshed during experiments every hour. 
 
4.4. Results and analysis 
4.4.1. Observation of Hah1MBD4 interactions in the presence of Cu1+ and 
identification of interaction complexes.  
We applied nanovesicle trapping in combination with smFRET to study 
Hah1MBD4 interactions in the presence of Cu1+. We first added one equivalent of 
Cu1+ per Hah1MBD4 pair in preparing nanovesicle trapped molecules. As Hah1 and 
MBD4 have similar Cu1+ binding affinities and their Cu1+ transfer is reversible,23, 27 
approximately half of the molecules of each protein have a Cu1+ bound at their CXXC 
sites at this condition. Therefore, among a population of Hah1MBD4 pairs trapped 
inside vesicles, there are pairs of apoapo, apoholo (i.e., either Hah1 or MBD4 has a 
Cu1+ bound), and holoholo proteins; and for a particular Hah1MBD4 pair, it can be 
in either one of these three Cu1+-loading states. 
 Figure 4.2A shows an exemplary EFRET trajectory of a single Hah1MBD4 pair 
inside a nanovesicle in the presence of one equivalent of Cu1+. The temporal EFRET 
fluctuations report the dynamic interactions between Hah1 and MBD4. Three distinct 
EFRET states are observed in this trajectory at EFRET ~0.2, ~0.5, and ~0.8, similar to the 
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dissociated state (E0 ~0.2) and the two interaction complexes (E1 ~0.5 and E2 ~0.8) 
observed for Hah1MBD4 interactions in the absence of Cu1+.37, 38  
 
 
Figure 4.2. Exemplary EFRET trajectories of a Cy5-Hah1 and a Cy3-MBD4 inside a 
nanovesicle in the presence of one equivalent (A) and four equivalents of Cu1+ (B). 
Trajectories are at 200 ms time resolution. 
 
Owing to the finite trajectory length (up to 12 min) limited by the 
photobleaching of the fluorescent probes, many EFRET trajectories only show two 
EFRET states within their time span. For the same reason, it is difficult to determine 
reliably the EFRET values of all three states from a single EFRET trajectory. To 
distinguish these three states and determine their EFRET values with statistical 
reliability, we used a 2-dimensional histogram analysis of EFRET values. For each of 
the EFRET trajectories that show merely two states, we calculated the average EFRET 
value of each state and assigned the smaller value as Elow and the larger value as Ehigh. 
We then plotted the 2-dimensional histogram of these two EFRET values from many 
trajectories (Figure 4.3B). For those EFRET trajectories that have three states and thus 
three EFRET values, we used any two out of the three values (there are three possible 
combinations of selecting two values out of three), assigned them as Elow and Ehigh 
based on their relative magnitudes, and added them onto the 2-dimensional histogram. 
Combining results from hundreds of single Hah1MBD4 pairs, the resulting 2-
dimensional histogram shows three distinct populations (Figure 4.3B), definitively 
indicating the presence of three EFRET states in Hah1MBD4 interactions in the 
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presence of one equivalent of Cu1+. These three populations are centered at the 
positions of (E0, E1), (E0, E2), and (E1, E2) in the 2-dimensional histogram (Figure 
4.3B). Projecting this 2-dimensional histogram onto the x,y axes and Gaussian-fitting 
the projections give the reliable EFRET values for the three states: E0 = 0.13 ± 0.06, E1 
= 0.50 ± 0.08, and E2 = 0.8 ± 0.1. For reference, the 2-dimensional histogram from 
single-pair apoHah1  apoMBD4 interactions is shown in Figure 4.3A, from 
which the determined EFRET values are E0 = 0.14 ± 0.07, E1 = 0.50 ± 0.08, and E2 = 0.8 
± 0.1, consistent with what we reported previously.37 
At one equivalent of Cu1+, there is a mixture of apoapo, apoholo, and 
holoholo pairs of Hah1MBD4. Consequently, the observed E1 and E2 states here 
could just be the two complexes from apoapo interactions in the population, and it is 
not yet clear if apoholo and holoholo interactions will also form multiple complexes. 
 To probe pure holoholo interactions, we added four equivalents of Cu1+ per 
Hah1MBD4 pair. The extra equivalents of Cu1+ are to ensure full occupation of the 
proteins’ copper binding sites. Further increasing the Cu1+ equivalents to six does not 
cause any significant changes in the Hah1MBD4 interactions (such as the histogram 
of the EFRET trajectories; see below), indicating that both proteins are already 
metallated in the presence of four equivalents of Cu1+.  
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Figure 4.3. 2-dimensional histograms of EFRET values of Hah1  MBD4 interaction 
states. (A) apoapo interactions. (B) In the presence of one equivalent of Cu1+. (C) In 
the presence of four equivalents of Cu1+. Elow, the EFRET value of the lower FRET state; 
Ehigh, the EFRET value of the higher FRET state in an EFRET trajectory. The projections 
of the histograms on the x,y axes are Gaussian resolved to determine the EFRET values 
of the three states: (A) E0 = 0.14 ± 0.07, E1 = 0.50 ± 0.08, E2 = 0.8 ± 0.1; (B) E0 = 0.13 
± 0.06, E1 = 0.50 ± 0.08, E2 = 0.8 ± 0.1; (C) E0 = 0.15 ± 0.08, E1 = 0.48 ± 0.07, E2 = 
0.8 ± 0.1. Data compiled from 309 (A), 420 (B), and 249 (C) Hah1MBD4 interacting 
pairs. 
 
 Figure 4.2B shows an exemplary EFRET trajectory of a single holoholo pair. 
Again, three states are observed at EFRET ~0.2, ~0.5, and ~0.8, corresponding to the 
dissociated state and the two interaction complexes, respectively. The 2-dimensional 
histogram of EFRET values definitively shows the three-state behavior of holoholo 
Hah1MBD4 interactions (Figure 4.3C). Therefore, the presence of multiple 
interaction complexes is general for both holoholo and apoapo interactions between 
Hah1 and MBD4. Furthermore, the EFRET values of the two holoholo interaction 
complexes are the same within experimental error as those of apoapo interactions 
(Figure 4.3C versus A), indicating that the overall interaction geometries of the 
complexes are unperturbed by Cu1+ binding in both proteins. Similarly, apoholo 
interactions between Hah1 and MBD4 also form two complexes, as will be shown 
below.  
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4.4.2. Cu1+-induced stabilization of apoholo interaction complexes.  
The real-time EFRET trajectories of single-pair Hah1MBD4 interactions also 
contain information about the stabilities of their complexes. Figures 4.4AC show the 
histograms of the EFRET trajectories of Hah1MBD4 interactions when they are in 
their apo-forms, in the presence of one equivalent of Cu1+, and in their holo-forms, 
respectively. All three histograms can be fitted by three Gaussian peaks, centered at E0, 
E1 and E2, corresponding to the dissociated state and the two interaction complexes, 
respectively. As the three peaks are not clearly resolved in these histograms, the peak 
locations were constrained to improve the reliability of the Gaussian fits, using the 
EFRET values determined from the analyses of the 2-dimensional EFRET histograms 
(Figure 4.3). The relative areas of the three peaks in each histogram represent the 
relative stabilities of the relevant states. For the apoapo Hah1MBD4 interactions 
(Figure 4.4A), the calculated dissociation constants of the two complexes are KD1~ 3 ± 
6 M and KD2 ~ 5  ± 9 M (the large error bars here mainly result from the size 
dispersion of the nanovesicles (inner diameter 80 ± 20 nm; see Experimental Section), 
from which the effective concentration of a single molecule inside is calculated).37, 38 
For holoholo Hah1MBD4 interactions, the relative areas of the three peaks 
in the histogram of EFRET trajectories are similar to those of apoapo interactions 
(Figure 4.4C versus 4A, and 4D). Therefore, there is no change in stability for both the 
E1 and the E2 complex when both proteins are loaded with Cu1+.  
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Figure 4.4. (A, B, C) Histograms of EFRET trajectories of single-pair Hah1MBD4 
interactions in the absence (A), or in the presence of one equivalent (B), or four 
equivalents of Cu1+ (C). Data compiled from 309 (A), 420 (B), and 249 (C) 
Hah1MBD4 interacting pairs. Each histogram is fitted with three Gaussian peaks, 
whose centers are set to the EFRET values determined from Figure 4. (D) The area 
ratios of the Gaussian-resolved peaks from A, B, and C. 
 
 In contrast, in the presence of one equivalent of Cu1+, significant changes are 
observed in the relative areas of the three peaks in the histogram of EFRET trajectories, 
as compared with those of apoapo Hah1MBD4 interactions (Figure 4.4B versus 
4A). Both the E1 and the E2 peak increase in their areas relative to that of the E0 peak, 
indicating an increase in the stabilities of the two interaction complexes (Figure 4.4D). 
At one equivalent of Cu1+, the Hah1MBD4 pairs contain a mixture of apoapo, 
apoholo, and holoholo forms. As each of the two complexes has similar stability in 
apoapo and holoholo Hah1MBD4 interactions, the increase in the stabilities of the 
two complexes here must come from the contribution of apoholo interactions. 
Therefore, apoholo interactions between Hah1 and MBD4 also form two complexes, 
both of which are stabilized relative to those in the apoapo interaction. 
 Interestingly, in the presence of one equivalent of Cu1+, the E1/E2 peak area 
ratio stays essentially the same as that in the apoapo interactions (Figure 4.4D). This 
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indicates that the two complexes are stabilized to a similar extent in apoholo 
interactions, as compared with those in apoapo interactions. 
 
4.4.3. Hah1 mutation eliminates Cu1+-induced stabilization of complexes.  
To probe if the observed Cu1+ stabilization effects on apoholo Hah1MBD4 
interactions are specific to their Cu1+ binding and transfer, we created a Hah1 mutant, 
mHah1, in which the two cysteines in the CXXC motif have been mutated to serines. 
Therefore, mHah1 cannot bind Cu1+ or accept Cu1+ from MBD4. Figure 4.5A shows 
the histogram of EFRET trajectories of single-pair mHah1MBD4 interactions in their 
apo-forms. Three EFERT states are observed, corresponding to the dissociated state (E0 
~0.2) and the two interaction complexes (E1 ~0.5 and E2 ~0.8). The relative areas of 
the three EFRET peaks in the histogram are the same as those of apoapo Hah1MBD4 
interactions, indicating that the cysteines in the CXXC motif of Hah1 are nonessential 
for the formation and the stability of apoapo interaction complexes. 
 
 
Figure 4.5. Histograms of EFRET trajectories of single-pair mHah1MBD4 interactions 
in the absence (A) and in the presence of one equivalent of Cu1+ (B). Each histogram 
is fitted with three Gaussian peaks, whose centers are set to the EFRET values 
determined from the 2-dimensional EFRET value analyses of the smFRET trajectories 
as in Figure 4.3. 
 
 In the presence of one equivalent of Cu1+, MBD4 can bind Cu1+, whereas 
mHah1 cannot. Thus, no Cu1+ transfer between mHah1 and MBD4 can occur. The 
histogram of EFRET trajectories of their single-pair interactions still shows three states, 
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and no significant changes are observed in either the positions of the three peaks or 
their relative areas (Figure 4.5B). Therefore, the Cu1+-binding by Hah1 and/or 
processes associated with Cu1+-transfer between Hah1 and MBD4 are responsible for 
the Cu1+-induced stabilization of E1 and E2 complexes in the apoholo Hah1MBD4 
interactions. 
 
4.5. Discussion 
 Using nanovesicle trapping combined with smFRET measurements, we have 
examined the dynamic interactions between single pairs of Hah1 and WDP MBD4 in 
the absence and the presence of Cu1+. The apoapo, apoholo, and holoholo 
interactions of Hah1 and MBD4 all lead to formation of two interaction complexes 
that interconvert dynamically. The stabilities of the two complexes do not change 
when both Hah1 and MBD4 are at their holo-forms, as compared with when both are 
in their apo-forms (Figure 4.4A, C). In contrast, when one protein is loaded with Cu1+, 
i.e., in the apoholo interactions, stabilization of both complexes is observed (Figure 
4.4B). This stabilization is abolished when the Cu1+ binding ability (and thus the Cu1+ 
transfer ability) of Hah1 is eliminated by mutating the cysteines in its CXXC motif 
(Figure 4.5). Interestingly, the Cu1+ effects on the apoholo Hah1MBD4 interactions 
do not differentiate the two interaction complexes; both the E1 and the E2 complex are 
stabilized to a similar extent (Figure 4.4A, B).  
 Fundamentally, the Cu1+-induced stabilization of protein complexes can be 
approximately divided into two types: one direct contribution, where the Cu1+ can 
bridge the two proteins at the interface via bonding with cysteines from both proteins; 
the other indirect contribution, where the Cu1+ binding to a protein causes changes in 
the protein’s conformation, leading to better complex formation. The direct 
contribution is possible for apoholo Hah1MBD4 interactions, in which one Cu1+ is 
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coordinated by cysteine ligands from both interacting partners, as described in the 
thiol ligand exchange mechanism for copper chaperone mediated copper transfer.5, 19, 
43  This metal-bridging was directly supported by the crystal structure of a Cu1+-
bridged Hah1 dimer20 and the NMR structure of a Cu1+-bridged complex between 
Hah1 and a MBD of MNK protein (Figure 4.6),50 as well as by computational 
studies.51 This Cu1+ bridging is not applicable for holoholo interactions, though, as 
both proteins here would have Cu1+ bound at their CXXC sites; consistently, no 
stabilization of protein complexes is observed in holoholo Hah1MBD4 interactions 
(Figure 4.4C).  
 The indirect contribution is likely not to play a significant role in stabilizing 
either Hah1MBD4 complex. This comes from the results on holoholo Hah1MBD4 
interactions, where only the indirect contribution is possible, but for which no 
stabilization of any protein complexes is observed (Figure 4.4C versus A). 
Using the NMR structure of the Cu1+-bridged Hah1MBD complex (Figure 
4.6)50 and knowing that our Cy3Cy5 pairs are located at the C-termini, the estimated 
Cy3Cy5 distance in this complex is ~5 nm. Using an EFRET versus distance 
calibration curve (unpublished results), this distance corresponds to an EFRET of ~0.5, 
similar to E1. Therefore, the E1 complex between Hah1 and MBD4 could be associated 
with the interaction geometry shown by this NMR structure. In the E2 complex, the 
Hah1 and MBD4 need to interact in a way that the distance between their C-termini is 
closer than that in the structure in Figure 4.6 to have a larger EFRET value (~0.8). At the 
moment, we do not know the structural identity of the E2 complex. SmFRET 
measurements only report structural differences along the coordinate of the 
donoracceptor interdistance. Future smFRET studies, where Cy3Cy5 are tagged at 
various locations on Hah1 and MBD4 to probe the structure of their complexes along 
multiple coordinates, may provide more information. 
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r ~ 5 nm  
Cy3 Cy5
MNK1 Hah1
r ~ 5 nm
 
Figure 4.6. NMR structure (pdb code: 2K1R)50 of a Cu1+-bridged complex between 
Hah1 and the first MBD of MNK. The positions corresponding to where the Cy3 and 
Cy5 are labeled are indicated; the anchor-to-anchor distance between the two labels is 
~5 nm. 
 
4.6. Conclusion 
 Using a nanovesicle trapping scheme in combination with smFRET 
measurements, we have studied the weak, dynamic interactions between the copper 
chaperone Hah1 and the MBD4 of WDP in the absence and the presence of various 
equivalents of Cu1+. We have visualized their interaction events in real time and 
identified their interaction complexes. Regardless of their metallation state, Hah1 and 
MBD4 can form two complexes that interconvert dynamically, an advantageous 
feature for their Cu1+-transfer function. Within the limit of smFRET in resolving 
structural differences along the coordinate of the FRET donor-to-acceptor 
interdistance, the interaction geometries in these two complexes appear invariable. 
The stabilities of the two interaction complexes are dependent on the proteins’ 
metallation state, though. When only one of the proteins has Cu1+ bound (i.e., 
apoholo Hah1MBD4 interactions), both complexes are stabilized relative to that 
observed in the apoapo interactions. Cu1+-bridging at the protein interface via 
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bonding to cysteines from both proteins is likely the cause of this stabilization. 
Consistently, this Cu1+-induced stabilization of interaction complexes is undiscernible 
when the Cu1+-binding cysteines in Hah1 are mutated to serines to eliminate its Cu1+ 
binding ability or when both proteins have Cu1+ bound (i.e., holoholo Hah1MBD4 
interactions). Based on its EFRET value, one of the complexes can be associated with a 
Hah1MBD4 interaction complex where the CXXC motifs from the two proteins face 
each other to offer cysteine binding to a bridging Cu1+ ion. The structure of the other 
complex is not yet clear. These Cu1+-induced effects on the Hah1MBD4 interactions 
provide a step toward understanding how the dynamic protein interactions of copper 
chaperones are coupled with their metal transfer function. 
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CHAPTER 5 
Concluding Remarks 
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5.1. Research summary 
In this thesis, the interaction dynamics between the copper chaperone Hah1 
and a single metal binding domain (MBD4) of the Wilson disease protein were studied 
at the single-molecule level using single-molecule fluorescence resonance energy 
transfer (smFRET). Since these interactions are relatively weak (KD ~10-6 M), they 
represent a challenge to study with single-molecule fluorescence techniques. The 
challenge resides in the requirement to have low fluorophore concentrations for spatial 
separation of individual molecules, thereby permitting single molecule optical 
detection. For a weakly interacting protein pair, concentrations must be high enough to 
allow for facile detection of the interaction complex. To overcome this challenge a 
nanovesicle trapping strategy was adapted to confine individual protein pairs to a 
reduced volume, effectively increasing their concentration. Furthermore, the overall 
number of vesicles can be kept low enough to allow for single-pair optical detection. 
Nanovesicle trapping has indeed resulted in a viable strategy to study relatively weak 
protein interactions and flexible enough to allow for different concentration regimes as 
well as experimental conditions by changing either the vesicle size or the lipid 
composition. In chapter 2, the details for the nanovesicle trapping approach and the 
single-molecule kinetic analysis of bimolecular interactions involving three states 
were presented. Both the experimental approach and the theoretical analysis are 
generally applicable for studying many other biological processes at the single-
molecule level. 
Using nanovesicle trapping, the interaction dynamics of Hah1 and MBD4 were 
characterized first in the absence of Cu+. These two proteins can bind  to each other in 
two distinct geometries which can interconvert dynamically. From the analysis of 
dwell-time distributions and the EFRET histogram, the interaction kinetics and 
thermodynamics were quantified. Functionally, the presence of two interaction 
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geometries increases the probability of complex formation when the two proteins  
encounter in the cell by diffusion. Also, having two interaction geometries suggests 
that either Hah1 or MBD4 might interact with multiple domains simultaneously. The 
study exemplifies the ability of nanovesicle trapping in combination with smFRET for 
studying weak protein interactions and provides insight into how Hah1 and WDP may 
collaborate to mediate Cu+ transfer inside cells. This study represents the first 
evidence that Hah1 and MBD4 can interact in the absence of Cu+ and that they do so 
in two different interaction geometries.  
To determine the Cu+-dependent interaction dynamics of Hah1 and MBD4, a 
set of experiments with different equivalents of Cu+ in the solution were performed. 
Regardless of the proteins’ metallation state, we observe multiple, interconverting 
interaction complexes between Hah1 and MBD4. Within our experimental limit, the 
overall interaction geometries of these complexes appear invariable, but their 
stabilities are dependent on the proteins’ metallation state. In apoholo Hah1MBD4 
interactions, the complexes are stabilized relative to that observed in the apoapo 
interactions. This stabilization is undiscernible when Hah1’s Cu+-binding is eliminated 
or when both proteins have Cu+ loaded. The results suggest that apo-holo interactions 
are stabilized due to metal bridging, presumably during Cu+ transfer. The observation 
that both interaction geometries are stabilized also suggests that both might be 
productive Cu+ transfer complexes. The structural identity of the E1 interaction 
geometry can be correlated to available structures of Hah1-MBD heterocomplexes. 
Yet, the identity of the second interaction geometry, E2, is unclear at the moment. 
Nevertheless, these Cu1+-induced effects on the Hah1MBD4 interactions provide a 
step toward understanding how the dynamic protein interactions of copper chaperones 
are coupled with their metal transfer function.   
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5.2. Further research 
Further analyses and experiments are necessary in order to scrutinize the Cu+ 
transfer process and dynamic behaviors of Hah1 and MBD4. To extract more detailed 
information on the apo-holo interaction processes, we need to extract the relevant 
information from the experiments in the presence of 1 equivalent Cu+, in which a 
mixture of apoapo, apoholo, and holoholo interactions exist. We can also label 
Hah1 or MBD4 at alternative sites to probe the geometries of the interaction 
complexes. Furthermore, to assess the copper transfer process we can design different 
protein mutants that can mimic the 3-coordinate copper transfer intermediate. Finally, 
once the copper dependent behavior is better understood we can probe the metal-
dependent behavior by performing experiments in the presence of different metals.  
 
5.2.1. The 1 eqv. Cu+ mixture problem   
 In chapter 4 we explain that experiments in the presence of one equivalent of 
Cu+ actually represent a mixture of conditions upon trapping in a nanovesicle. Some 
vesicles will contain a pair of apo proteins, some will have a pair of holo proteins and 
still some will contain an apo-holo combination. The fraction of vesicles containing 
any combination of proteins will depend on the concentrations of each species in 
solution, assuming equal entrapment probability. As an initial approximation, we can 
assume that in the solution there is only one chemical equilibrium: 
 
  
where there are only four different protein species: Hah1-Cu, Hah1, MBD4-Cu, and 
MBD4. Using the equilibrium constant for copper exchange (KExchange) and the total 
protein and copper concentrations, the individual concentrations of each protein 
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species can be readily calculated. Using the individual concentrations we can calculate 
the probability of finding any particular protein species in solution. It then follows that 
the joint probability of obtaining any protein pair is easily calculated (Figure 5.1). For 
this approximation we assume equal entrapment probability and that all copper is 
bound to protein. Due to the high copper binding affinity of Hah1 and MBD4 (KCu ~ 
10-10 M) assuming that all the copper is protein-bound is not unreasonable. 
Once the contribution of each type of trapped protein pair is determined, the 
pure apo-holo contribution can be extracted. For either EFRET or dwell-time 
distribution, the data represents a weighted linear combination of each contribution 
(i.e. apo-apo, apo-holo, and holo-holo). This strategy only works if we know the 
behavior for pure apo-apo and holo-holo interactions.   
 Upon further inspection of this type of analysis we can formulate many 
additional processes occurring in solution that will affect the concentrations for each 
one of the proteins. We can include Hah1 dimerisation1 and MBD4 dimerisation, both 
in the presence and absence of Cu+ (i.e. apo-apo, holo-holo and apo-holo homo-
dimers). We should also take into consideration the different hetero-complexes that 
can form in solution and be trapped as a single body, such as Hah1-MBD4 complexes 
of the three types: apo-apo, apo-holo and holo-holo. 
These considerations complicate the analytical expressions for determining the 
probability of finding any specific protein pair, and some of the equilibrium constants, 
such as those for dimer formation, are not yet known. Therefore, further experiments 
are necessary to determine these constants. Also further analysis is necessary to 
determine to what extent the additional parameters affect the final determination of the 
probability of finding any particular protein pair in the nanovesicle. 
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Once we can resolve the apo-holo contributions in the 1 equivalent Cu+ 
condition, we can analyze in more detail the contributions from Cu+ transfer and 
extract detailed kinetic information regarding the Cu+ transfer process itself.  
 
 
Figure 5.1. Trapping probability equations for simplest scheme. A. Initial set of 
equations. B. Individual protein concentrations in solution prior to trapping. C. 
Probability of finding each protein species. D. Joint probabilities for apo-apo, apo-
holo and holo-holo. In this model we assume all Cu+ to be protein-bound.  
 
5.2.2. Alternative labeling schemes 
 To investigate the structural identity of the E2 complex we propose in chapter 4 
that alternative labeling schemes could be used in combination with the available 
structural data from the literature to map out the interaction geometries. At the 
moment all experiments were done with the fluorescent label at the C-termini. An 
alternative labeling position could be closer to the metal binding motif of either 
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protein thus making the E1 state a higher EFRET state and see how E2 is affected (Figure 
5.3). In this fashion we can map out the different interaction geometries by 
systematically changing either protein’s labeling position.    
Cy3
Cy5
Mnk1 Hah1
r = 3.5
EFRET = 0.7   
Figure 5.3. NMR structure (pdb code: 2K1R)2 of a Cu1+-bridged complex between 
Hah1 and the first MBD of MNK. The positions corresponding to where the Cy3 and 
Cy5 may be labeled are indicated; the anchor-to-anchor distance between the two 
labels would be ~3.5 nm. The expected EFRET is approximately 0.7. 
 
5.2.3. Assessing the 3-coordinate Cu+ transfer intermediate 
O’Halloran and others3-7 have proposed that Cu+ transfer between Hah1 and 
the MBDs of WDP occurs via a thiol exchange mechanism through a 3-coordinate Cu+ 
intermediate (Figure 5.2).  
In order to probe this interaction intermediate, a mutant of Hah1 will be 
prepared in which one of the metal binding cysteine residues is mutated to alanine, 
specifically Cys15. From the two cysteine residues that coordinate copper in Hah1, 
cysteine 12 is the most solvent exposed and is proposed to be the first cysteine residue 
to bind copper during the transfer process.2, 5, 7  
This type of experiment provides two major advantages. First, all interactions 
observed will most likely be apo-holo interactions, as the binding affinity for copper is 
very high (KCu ~ 10-10 M) and only one protein can bind Cu+, thereby eliminating the 
107 
mixture problem in the 1 equivalent Cu+ experiment. Second, we will be able to probe 
this initial 3-coordinate interaction intermediate involved in the Cu+ transfer process.  
 
 
Figure 5.2. The ligand exchange mechanism of Cu+ transfer through a 3-coordinate 
intermediate between Hah1 and a MBD domain of WDP. 
 
 5.2.4. Metal dependence of interactions  
   Up to now we have probed interactions in the presence of varying equivalents 
of Cu+, which is the biologically relevant metal. Other studies suggest that the 
interactions and metal transfer between Hah1 and the MBDs of WDP, although 
functionally geared for Cu+, can also occur in the presence of Hg2+.8 Up to now, 
various structures have been solved for Hah1 and the MBDs in the presence of 
different transition metals such as Cu+, Cd2+, and Hg2+.3 Next we can perform 
experiments in the presence of different metal ions to probe the metal-dependent 
behavior of Hah1 and MBD4 interactions. We have performed preliminary 
experiments in the presence of 1 equivalent Hg2+. The results are similar to those 
observed in the presence of Cu+ (Figure 5.4). Hg2+ dependent experiments are 
necessary to fully assess the effect of Hg2+ on the interaction dynamics.  
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Figure 5.4. EFRET histogram of Hah1MBD4 interactions in the presence of 1 
equivalent of Hg2+ (250 molecules). 
 
5.3. Research outlook 
 The single domain study represents the simplest system available to scrutinize 
the interactions between the copper chaperone Hah1 and the MBDs of WDP. It 
provides the fundamental interaction dynamics applicable to either Hah1-MBD or 
MBD-MBD interactions. We can probe the fundamental interaction dynamics, Cu+ 
transfer intermediates, and metal dependence of interactions. This system represents a 
stepping stone to increase system complexity. It is essential to fully scrutinize this 
system in order to better understand the more complex interaction dynamics of a 
multi-domain system, such as Hah1’s interactions with the full 6-domain construct of 
the metal binding domains of WDP, or even MBD-MBD interactions within WDP.  
Overall, we have contributed to a better understanding of the fundamental 
interaction dynamics of Hah1 and MBD4 in the presence and absence of Cu+ as well 
as provided structural insight on the interaction process for metal transfer. It is clear 
that there are still many studies that can be performed with this system, ensuring long 
lasting continuation of the project.    
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